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Abstract 
 
 RNA is an important constituent of the nucleus with functions including regulation of RNA 
biogenesis, regulation of gene expression, and dosage compensation. Currently used 
technologies to study RNA chromatin interactions pull down individual RNAs and sequence the 
associated DNA. However, it remains challenging to identify chromatin associated RNAs and their 
genomic target sites. In this thesis, I will describe MARGI-seq, a method to identify chromatin 
associated RNAs and their genomic target sites in one unbiased experiment. This method thus 
challenges the one-RNA-at-a-time paradigm of currently available technologies. The technique 
involves ligating RNA and DNA together via a novel linker and sequencing these chimeric 
molecules via paired end next generation sequencing. We have developed two variations to this 
protocol called proximity MARGI (pxMARGI) and direct MARGI (diMARGI). pxMARGI identifies all 
RNA and DNA in close proximity, while diMARGI prioritizes protein mediated direct interactions. 
 
 We have applied this technique to study RNA-chromatin interactions in three cell types, 
mouse E14 embryonic stem cell line, human H9 embryonic stem cells and human HEK 293T cells. 
Among the top caRNAs identified by MARGI were several nuclear body associated RNAs including 
SNHG1, MALAT1, NEAT1 and XIST. 80 – 95% of the DNA targets of caRNA were observed to be 
connected to the loci of RNA transcription, 1-2% were observed to be on the same chromosome 
but distal to the loci of RNA transcription and about 5 – 10 % of the DNA targets were observed 
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to be inter-chromosomal connections. RNA attachment levels were observed to be positively 
correlated to H3K4me3 and H3K27Ac levels and negatively correlated to H3K9me3 levels.  
 
 We also developed a new plasmid called pCRISPTET as an easily clonable system to tether 
RNA of interest to specific genomic loci based on the CRISPR-display technique.  Gibson assembly 
can be used to introduce RNA of interest, while golden gate cloning can be used to clone in the 
PAM  sequence to provide information regarding the genomic loci of interest. We used pCRISTET 
to study the effect of tethering lncRNA EVX1as to the EVX1/ EVX1as promoter region. 
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Chapter 1: Introduction 
 
1.1 RNA-Chromatin interaction 
 
ENCODE data has shown that while 75% of the human genome is transcribed, only about 
2% resides in coding regions1. The RNAs which do not code for proteins, non-coding RNAs 
(ncRNAs), thus account for a vast majority of transcribed sequences. Some of the classical ncRNAs 
such as ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs) have very well characterized 
functions. Some other ncRNAs such as microRNAs, small interfering RNAs (siRNAs), and small 
nucleolar RNAs (snoRNAs) have also been well studied. But a vast majority of non-coding RNAs 
remain unidentified and poorly understood. Indeed, till recently, they were referred to as junk 
RNA. Overall, about 10% of the genome is annotated1. Thus, though the cells expend a vast 
amount of energy to produce these RNAs we do not know what role a vast majority of these 
RNAs play in cellular function. 
 
Long non-coding RNAs (lncRNAs) are non-coding RNAs that are greater than 200 
nucleotides long. lncRNAs may share many features with mRNA including 5’ capping, splicing, 
and polyadenylation but have almost no open reading frames (ORFs)2. ncRNAs are a broad term 
that covers multiple RNA types including small nucleolar RNA, intergenic transcripts, transcripts 
that overlap other genes, etc. On average lncRNA expression levels are lower than protein coding 
RNA though this varies by class1,3. Long non-coding RNAs have been associated with several 
physiological processes including maintaining stem cell pluripotency, mediating immune 
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response and cell cycle progression. Some specific examples include Xist4, which is involved in 
dosage compensation and lnc135, which has been associated with susceptibility to celiac disease. 
 
One hypothesis for the role of ncRNA that has come under increased scrutiny is the role 
that they play in modulating epigenetic events at the chromatin. It has been hypothesized that 
long non-coding RNAs have a role to play in creating unique epigenetic profiles6,7. A cis-acting 
and a trans-acting model of RNA-mediated epigenetic modulation has been proposed6. Non-
coding RNAs, like XIST, have been shown to have a role in guiding chromatin modifying enzymes 
and other proteins to specific genomic loci that they have been transcribed from. These are 
considered as cis-acting effects of RNA on chromatin structure. In other cases, non-coding RNA 
can direct chromatin modifying enzymes to genomic loci other than those from which they are 
transcribed, through non-Watson-Crick base pairing or by acting as a scaffold molecule that 
assembles regulatory enzyme and is itself targeted to specific genomic loci by other adapter 
proteins. This can be considered as the trans-acting effects of RNA on chromatin. As trans-
regulators, it has also been proposed that non-coding RNA can have a role in allosteric regulation 
of some enzymes or as a decoy molecule that can sequester enzymes away from the chromatin. 
Specifically, long non-coding RNAs have been shown to modulate chromatin structure to 
facilitate processes such as dosage compensation, transcriptional gene silencing and imprinting 
of genes.  
 
Despite the growing body of evidence implicating non-coding RNA in cellular regulation, 
there have been very few reported techniques to identify chromatin interacting RNA. There have 
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been a few reported techniques that can identify the genomic targets of known chromatin 
interacting RNAs. Three major reported techniques that achieve this objective are RNA antisense 
purification – seq (RAP-seq)4 Chromatin Isolation by RNA purification coupled with sequencing 
(ChIRP-seq)8 and Capture hybridization analysis of RNA targets (CHART)9. These techniques use 
slightly different strategies to pull down specific RNA and then sequence the chromatin that is 
associated with this RNA. However, these techniques suffer from the obvious drawback that they 
can be applied to only one RNA molecule at a time. Also, researchers need to know the RNA that 
interacts with the chromatin to perform these assays. This is also a major drawback as ncRNAs 
are still not very well characterized and only very few ncRNAs with possible chromatin interacting 
functions are known.  
 
A brief survey of some reported chromatin interacting RNAs and their genomic targets 
along with the methodology used to identify these targets has been summarized in table 1.  
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Table 1: Reported genomic targets of non-coding RNA. lncRNAs with published genomic target 
sites and the method used to identify this interaction is summarized below.  
lncRNA Cell Type Assay 
roX2 s2 Drosophila cells ChIRP seq8 and CHART seq9 
TERC8 HeLa S3 transduced with TERC ChIRP seq 
HOTAIR8 MDA-231 cell line overexpressing human 
HOTAIR with EZH2 knocked down 
ChIRP seq 
Xist4 Female mouse lung fibroblasts  RAP seq 
Xist10 Female E.S cells on a differentiation time 
course 
CHART seq 
DA12594211 C28/I2 and chondrogenically differentiated 
BDE fibroblasts 
ChIRPqPCR 
RMST12 Differentiating ReN-VM cells in N2B27 
medium 
ChIRP qPCR 
PCGEM113 LnCAP cells ChIRP seq 
PRNCR113 LnCAP cells ChIRP qPCR 
116HG14 WT and Snord116del (+/-) mouse brain ChIRP seq 
7SK snRNA HEK293T15 cell and mouse ES16 ChIRP seq 
MALAT117,18 MCF-7, male mESC CHART seq, RAP-DNA 
NEAT117 MCF-7 CHART seq 
DACOR119  V852 expressing DAOCAR1 lentivirus ChIRP seq 
FOXC120 Human breast cancer cells ChIRP seq 
PAN 21 Kaposi's sarcoma cell culture ChIRP seq 
LED22 MCF-7 ChIRP seq 
h5S-OT23 HEK293T cell ChIRP qPCR 
EVX1as24 d4 lif(-) mouse ES ChIRP seq 
Firre25 
 
Male mESC 
 
RAP seq 
 
U118 Male mESC RAP-DNA 
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Currently, there are no reported methods that can identify chromatin interacting RNA 
and their genomic targets in a global and pairwise manner. In chapter two of this thesis, I will 
describe the development of a new methodology, MARGI (mapping RNA-genome interactions) 
to identify chromatin interacting RNAs and their genomic target sites in a pairwise, unbiased 
manner. We developed two variations of the methodology – called proximity MARGi (pxMARGI) 
and direct MARGI (diMARGI) respectively. 
 
In pxMARGI, RNA and DNA that are in close spatial proximity by virtue of being part of the 
so-called chromatin cage would be detected26. In this chromatin cage model, the chromatin 
forms an interweaving mesh. RNA can get trapped in this mesh and not necessarily have direct 
protein-mediated or base paired interactions. However, several of the more prominent published 
interactions have been shown to be mediated via protein bridges4,27,28. To prioritize these direct 
interactions, we have developed a variation of the MARGI protocol called diMARGI.  
 
After developing this technique first in a mouse embryonic stem cell line, E14, we applied 
it in two human cell lines, H9 (human embryonic stem cells) and HEK 293 T cells. In chapter three, 
I will discuss the RNAs we observed in these cell lines and their genomic targets. I will also discuss 
a few differences we observed between these cell types. 
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1.2 Nuclear RNA 
 
 As mentioned earlier, there is a lot of existing literature on nuclear RNAs. I will provide 
some additional background on a few important classes of these RNAs in this section of the 
introduction. 
 
 1.2.1 Uridine rich Small Nuclear RNA 
  
 Uridine rich Small nuclear RNA (UsnRNA) is a sub-class of nuclear RNA that is widely 
associated with the spliceosome.  There are two classes of UsnRNAs – sm and Lsm snRNAs29. The 
sm class consists of U1, U2, U4, U4atac, U5, U7, U11 and U12. The Lsm class consists of U6 and 
U6atac. With the exception of U7, all the other snRNAs are associated with the spliceosome. The 
U7 snRNA is associated with the 3’ processing of histone pre- mRNA. The function of the 
spliceosome is to catalyze the removal of introns from pre-mRNA. While the spliceosome is a 
RNA-protein complex, evidence suggests that RNAs in the spliceosome have some catalytic 
function as well30. Splicing is an intricate reaction that involves the coming together of multiple 
complexes. The 5′ splice site first recognized by base pairing interactions with U1 and U2 snRNAs. 
The U1 snRNA is then replaced by u6 snRNA.  The subsequent exon that will be joined to the first 
exon is maintained in its position via interactions with a  conserved loop in U531. In addition to 
coordinating the positions of the exons, there is evidence to show that the snRNAs are also 
involved in the catalysis of the splicing reaction32,33. Within the nucleus, the snRNA and the 
components of the spliceosome form a punctate distribution called as nuclear speckles34. These 
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nuclear speckles have been observed to form close to actively transcribing genes35 but do not 
necessarily contain DNA themselves36. Evidence suggests that speckles act as storage 
compartments to provide splicing factors to process RNA from actively transcribing genes37. 
 
 The interactions of the U1 snRNA with the chromatin have been studied using RAP-seq18. 
A bimodal distribution of interaction sites with genes was observed. A sharp interaction peak at 
the 5’ ends of genes and a broader interaction peak at the 3’ ends of genes was observed. The 5’ 
peak was seen to be independent of transcription of nascent mRNA, while the peak at the 3’ end 
was dependent on the transcription of nascent mRNA. 
 
 1.2.2 C/D and H/ACA RNAs 
 
 Small nucleolar RNA (snorRNAs) is another abundant class of RNA present in the nucleus. 
It is associated with the nucleolar sub-compartment. snoRNAs are divided into two sub-families 
– the C/D and H/ACA snoRNAs. While most snoRNAs are indeed associated with nucleolus and 
rRNA biogenesis, they also have roles that go beyond this function. Thus, while all snoRNAs 
belong to these families, not all C/D or H/ACA family RNAs localize to the nucleolus. These other 
roles require different sub cellular localizations especially to access substrates 29. Some of these 
RNAs are required to perform modification on snRNA and are localized in the Cajal bodies and 
are called as scaRNAs. snoRNAs are one of the largest classes of ncRNAs with over 200 unique 
members38 and are associated with diverse cellular roles39.  They are present in both eukaryotes 
and archae40. 
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 The primary function of the two sub-families of snoRNAs is to guide different chemical 
modifications of RNA. The C/D family of snoRNAs guides 2’-O-Ribose methylation whereas the 
H/ACA family directs pseudouridylation of RNA. These modifications are extremely important to 
rRNA and ribosomes cannot function without these modifications41.  
 
 Besides rRNAs, these RNAs also modify snRNAs. This function is carried out in the Cajal 
bodies42. Other targets include tRNAs in archaea43 and a brain-specific mRNA44,45. One H/ACA 
family RNA has been shown to be involved in telomere synthesis46. Besides, there exist several 
C/D and H/ACA RNAs whose function have not yet been determined thus keeping open the 
possibility that these RNAs might have other novel functions29. 
 
 1.2.3 LncRNAs and other prominent nuclear RNAs 
 
 7SK snRNA 
 
 7SK snRNA is lncRNA involved in the regulation of transcription. It works by interacting 
with positive transcription elongation factor, pTEFb.  When pTEFb is bound to 7SK snRNA, it is 
inactive as its kinase function is suppressed. About half the cellular pTEFb is bound to 7SK snRNA. 
Brd4 is a protein that is capable of releasing 7SK snRNA from pTEFb. The molecular mechanism 
of this pause release at a large subset of transcriptional units called anti-pause enhancers that 
have cobound jumonji C-domain-containing protein 6 (JMJD6) and bromodomain-containing 
protein 4 (Brd4) was recently published. In published data. Liu et. al have shown that 7sk snRNA 
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acts as a reader of H4R3me2 and binds to chromatin15. Brd4 dependent recruitment of JMJD6 
causes erasure of H4R3me2 and thus release of 7sk snRNA. In their paper, Liu et. al performed 
ChIRP-seq of 7sk snRNA and discovered the chromatin interaction sited of this ncRNA 
 
 XIST, MALAT and NEAT1 are three highly conserved lncRNAs in mammals that have very 
distinct sub-nuclear localizations. They are discussed in detail below. 
  
XIST 
 
 XIST is a lncRNA involved in dosage compensation in mammals47. Dosage compensation 
is the process by which transcription from an unequal number of sex chromosomes is equalized 
for the non-sex specific genes encoded from these chromosomes. In mammalian cells, one of the 
X chromosomes is silenced by a complex including Xist48. XIST binds to the X chromosome from 
which it is transcribed from and spreads across the chromosome. This is followed by multiple 
processes such as appearance of repressive marks, removal of active marks and exclusion of RNA 
pol II. Almost all the genes in the chromosome it coats are silenced. 
 
 XIST is 17 kb long lncRNA. It is capped, spliced and poly-adenylated but retained in the 
nucleus. The mechanisms by which XIST performs its silencing have been researched for decades 
now and have been reviewed extensively49. Xist expression in cis has been shown to be both 
necessary and sufficient to cause inactivation of the chromosome from which it expressed50. The 
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choice of X chromosome to be inactivated is random and controlled by other factors in the X 
inactivation center49.  
  
 Xist localization in the nucleus has been studied by two independent methods, CHART-
seq and RAP-seq4,10. Broadly from both these methodologies, it was observed that Xist initially 
binds to few specific loci and then spreads across the X chromosome. Initially, the silent genes 
were coated, and then Xist spread across to active genes as well. Engreitz et al4 also showed that 
the spread of Xist appeared to be correlated with the 3D structure and topology of the 
chromosome on which Xist was spreading.  
 
 A large number of studies have also delved upon the question of how Xist causes its 
silencing effects. Using ChIRP-MS and RAP-MS the proteins associated with Xist have been 
identified51–53. Xist is thought to first interact with the chromatin and cause histone deacetylation 
and RNA pol II exclusion52.  PRC2 has also been strongly implicated in this regard. Both the CHART-
seq and the RAP-seq data showed correlation of XIST binding with PRC2 peaks on X chromosome. 
However, there is a very strong debate as to whether there is a direct interaction between Xist 
and PRC2 or if this interaction is indirect. There is evidence supporting both the hypothesis47.  
  
 MALAT1 and NEAT1 
 
 MALAT1 (metastasis associated in lung adenocarcinoma transcript 1) gene, is a lncRNA 
that was initially identified due to it being overexpressed in several cancers54,55. Since the initial 
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reports, Malat1 has been reported in several other publications on its role in cancer56. However, 
expression of MALAT1 is not restricted to cancer and it is expressed across cell types57. It has 
been shown to be localized to the nuclear speckles 34. However, it is not essential to the 
development of mice or the formation of nuclear speckles58. The interaction of MALAT1 with the 
genome has been studied using CHART-seq17 and RAP-DNA18. Using these techniques, it was 
observed that MALAT1 colocalizes to actively transcribed genes. Also, it usually accumulates 
closer to the 3’ end of these genes. 
 
 Being a part of the nuclear speckles, a role for MALAT1 in modulating splicing has been 
hypothesized. MALAT1 has been shown to interact with the SR family splicing factors and 
modulate their phosphorylation status59. As stated earlier, MALAT1 knockdown does not affect 
the overall formation of nuclear speckles. Thus, inhibition of MALAT1 only affects a subset of 
transcripts. Thus, MALAT1 most likely has a tissue or development stage dependent function. 
Additionally, MALAT1 has been shown to have functions in affecting the gene expression of other 
genes60 as well as affect gene expression during cell cycle progression61,62. 
  
 NEAT1 (nuclear enriched abundant transcript 1), is a neighboring lncRNA of MALAT1 and 
is encoded about 30 kb 5’ to MALAT1. NEAT1 has been shown to be localized to and essential for 
the formation of the paraspeckles63. The role of the paraspeckle is still under active study and 
not fully understood. However, they contain splicing factors and have been shown to have a role 
in sequestering RNA during cellular stress64. However, paraspeckles have been shown to not be 
essential in mice65.  NEAT1 genomic localization has been studied using CHART-seq17 as well. 
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NEAT1 also was shown to have a preference for actively transcribing genes like MALAT1. In fact, 
MALAT1 and NEAT1 shared a large number of gene targets. However, NEAT1 typically bound to 
the 5’ end of the genes. 
  
 1.3 CRISPR tethering 
 
 The CRISPR(clustered regularly interspaced palindromic repeats) Cas9 system have 
completely revolutionized the field of genome engineering66,67. The CRISPR system was first 
discovered as the adaptive immune system of bacteria68–71. The mechanism of action was shown 
to involve the breaking of double stranded DNA, and the system was shown to be 
programmable72–74. Three different kinds of CRISPR systems have been reported. Types I and III 
require a wide variety of Cas proteins to function whereas type II systems require just one, Cas9. 
This property has led to this system being especially useful for genome engineering applications. 
  
Briefly, while conferring immunity in bacterial cells, the CRISPR-Cas 9 system requires the 
insertion of the invading DNA in the CRISPR array as a spacer sequence. This portion is then 
transcribed into a pre – CRISPR RNA (pre crRNA) that matures into a crRNA. This crRNA consists 
of a repeat region and an invader-specific region. This crRNA then directs the Cas proteins to the 
infecting DNA to the specific loci where the Cas proteins can cleave the DNA. Specifically in type 
II CRISPR systems of the human pathogen Streptococcus pyogenes, a trans activating crRNA was 
found to be required for the maturation of crRNA. The tracrRNA-crRNA duplex was together 
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required for the DNA cleavage. This duplex was then engineered into a single system called the 
sgRNA for genome engineering73. This sgRNA has the sequence of the targeted DNA at the 5’ end 
and the sequence corresponding to the tracrRNA:crRNA duplex required for the Cas9 binding at 
the 3’ end. This system was then quickly built upon to develop RNA-guided genome editing in 
human cells75–77. 
 
 The Cas9 protein is the protein that performs the DNA cleavage in type II CRISPR-Cas9 
systems. Cas9 has two domains, the HNH domain and the RuvC-like domain that perform the 
cleavage. The HNH domain cleaves the DNA strand complementary to the 20-nucleotide 
sequence of the crRNA; the RuvC-like domain of Cas9 cleaves the DNA strand opposite the 
complementary strand. The Cas9 can be deactivated by mutating two amino acids to mutate 
these domains, Asp10 → Ala, His840 → Ala. These mutaƟons result in an RNA-guided DNA binding 
protein73,78.  
 
 This CRISPR-dCas9 system can be used to deploy payloads to various targets on the 
genome. Shechner et. al used this system to deploy RNA payloads including lncRNA several kbs 
long to sites on the genome79. They have tested multiple constructs with RNA at different 
locations relative to the genome targeting sequences and the crRNA:tracrRNA duplex regions. 
They also applied transcription by using two different promoters, the U6 promoter and the CMV 
promoter. The U6 promoter would not work for larger constructs while the CMV-driven promoter 
would. Besides testing with artificial constructs, they also tested the effect of introducing natural 
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lncRNA on transient expression of luciferase gene via a gLuc plasmid. The expression of luciferase 
changed in the same direction as expected from the lncRNA. However, these changes were 
modest. Luo et. al applied this method to test the effect of EVX1as lncRNA at the EVX1/EVX1as 
promoter80. 
 
 In chapter four, I describe a plasmid system that I have developed called pCRISPTET to 
make CRISPR tethering of RNA easier. In this convenient plasmid system RNA of interest and 
target genomic sequence can easily be inserted.  
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This chapter contains material previously published in Sridhar, B. et al. Systematic Mapping of RNA-Chromatin Interactions 
In Vivo. Curr. Biol. 27, 602–609 (2017). 
Chapter 2: Development of MARGI-seq 
 
We have developed a methodology to identify chromatin associated RNAs and their 
genomic interaction sites called Mapping RNA – Genome Interaction (MARGI – seq). In this 
chapter, I will provide you with the details of this protocol, the logic behind the various steps and 
the optimizations that went into developing it. 
 
2.1 – Protocol development 
 
We have designed a proximity ligation based strategy to identify RNAs that interact with 
the genome and their genomic target sites. Briefly, this strategy involves first crosslinking 
chromatin. In the case of pxMARGI, crosslinking was done using 1% formaldehyde. In the case of 
diMARGI, a dual crosslinking strategy was used to maximize the crosslinking of proteins to each 
other. Crosslinking was carried out by using 3% formaldehyde and disuccinimidyl glutarate (DSG). 
Genomic DNA was then fragmented by a type II restriction enzyme in the case of pxMARGI or by 
sonication in the case of diMARGI. Sonication also causes the solubilization of chromatin. In the 
case of diMARGI, the soluble portion was separated from the insoluble portion prior to 
proceeding with the following steps. Proteins are then biotinylated and crosslinked complexes 
are immobilized on streptavidin beads. This helps perform buffer exchanges for downstream  
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reactions and is also shown to increase specificity in other proximity ligation assays81. RNA in the 
cells are then ligated to a biotin tagged linker. This linker is designed in such a manner that it can 
also be used as the adapter for generating sequencing library in a downstream step. The RNA 
ligated linker is then proximity ligated to DNA using T4 DNA ligase. After ligation, crosslinking is 
reversed, and the nucleic acids are isolated. Biotin in any linker that is only ligated to RNA will 
then be clipped using exo I and T 4 DNA polymerase using its 3'->5' exonuclease activity82. 
Chimeras are then selected based on the biotin tag in the linker. Once pulled down, the RNA will 
be reverse transcribed on the Streptavidin beads itself. At this stage, one strand would contain 
RNA-linker-DNA. The other strand would be cDNA-linker-DNA. The pulled down material will then 
be denatured and the strands separated. The strand containing the RNA would continue to be 
attached to the beads (because of the position of the biotin in the linker) and the other strand 
would get separated into the supernatant. This strand will then be circularized and restriction 
digested in the middle of the linker region. This would lead the linker to appear at the two ends. 
These linkers have been designed in such a manner that they can bind to the Illumina sequencing 
primers and sequenced on an Illumina sequencer. Sequencing primer 1 will be proximal to the 
cDNA and the sequencing primer 2 will be proximal to DNA. Thus, the sequencing file for read 1 
should provide us information about the RNAs that are proximal to the chromatin and the file for 
read 2 will provide us with information for the targets of these RNAs. 
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Fig 1:  MARGI-seq experimental pipeline. Crosslinked cells are subjected to fragmentation 
either by restriction enzyme digestion (pxMARGI) or by sonication (diMARGI). The proteins are 
biotinylated and localized onto streptavidin beads to aid buffer exchanges. Biotin tagged linker is 
first ligated to the RNA and then to DNA. The nucleic acids are extracted from the beads by 
performing reverse crosslinking and protein digestion. After removing the biotin from linker 
molecules that ligated only to RNA, chimeras are pulled down using streptavidin. The RNA is 
reverse transcribed and the strand containing cDNA is eluted by denaturing using NaOH. This is 
circularized and digested to bring the linker to the ends and then used for library generation and 
sequencing. 
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2.2 Linker design 
 
The linker design is an extremely important element of this strategy. The linker has been 
designed such that it contains a biotin tag that can be used to pull down chimeras. One side is 
able to attach only to RNA and the other only to DNA. This is achieved by designing one end of 
the linker to be single stranded. The single stranded end is adenylated and T4 RNA ligase 2 
truncated KQ can be used to ligate this to RNA. This enzyme has the advantage that it can ligate 
pre-adenylated DNA to RNA without the presence of ATP. It also cannot ligate single stranded 
RNA to single stranded RNA. Thus, non-specific RNA ligations will be minimized. The other end of 
the linker is double stranded with a dT overhang. This dT can hybridize with a dA tail that is 
provided to fragmented DNA and then this can be efficiently ligated to DNA. The linker also serves 
as the primer for reverse transcriptase to catalyze its reaction. The linker also acts as a basis for 
sequencing library generation. After circularization and digestion at the internal BamH1 site, the 
linker sequences will appear at the two ends of the DNA sequence. The presence of other BamH1 
sites in the DNA will not affect this process as BamH1 requires double stranded DNA in order to 
perform restriction digestion. The DNA is single stranded at this point except for the linker region, 
where an oligo is annealed prior to restriction digestion. Due to this, a cut will be introduced only 
at the linker leading the linker to be positioned at the ends of the molecule. These sequences are 
designed in such a manner that sequencing primer 1 binds to end that will lead to information 
about RNA and sequencing primer 2 binds to the end providing information about their genomic 
targets. Due to this and the restriction digestion of the DNA, the read 2 will always begin with the 
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restriction enzyme signature CC bases in the case of pxMARGI but not in the case of diMARGI.  As 
the biotin tagged linker is also being used for sequencing library generation, downstream 
inefficiencies of attaching sequencing linkers are avoided. The entire process is shown in fig. 2.   
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. (A) Linker sequence. The linker is composed of double-stranded DNA in the center 
and single-stranded DNA on the two ends. The top strand of the linker is 11 bases longer than 
the bottom strand, leaving 10 bases of single-stranded DNA at the 5’ end and 1 base of single- 
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Fig 2 (...continued) stranded DNA at the 3’ end. The 5’ end of the top strand is adenylated (5’ 
App) and the 5’ end of the bottom strand is phosphorylated (Phos). N: random base. Letters in 
blue: BamHI restriction site. (B) RNA-Linker ligation. RNA with 3’-OH was produced by T4 PNK 
treatment.  (C) Linker-DNA ligation. A single base “A” tail (in red) is added to the 3’ end of DNA, 
which enables a sticky-end ligation to the linker. (D) Circularization and re-linearization. After 
BamH1 digestion, the linker sequence is split and re-allocated to the two ends, which were by 
design complementary to the library construction primers. (E) Another perspective of the ligation 
and reverse transcription steps as shown in A-D.   
 
While the basic description provided above is the same for both the protocols we 
developed, there were several differences between the two as well. These differences helped 
prioritize the direct protein mediated interactions in the case of diMARGI. The differences are 
summarized below: 
 
1. Crosslinking: In the diMARGI protocol, a dual crosslinking protocol was used. Cells were 
first crosslinked with DSG followed by crosslinking with 3% Formaldehyde. In the pxMARGI 
experiment cells were crosslinked only with 1% formaldehyde. 
 
2. Fragmentation: Chromatin was fragmented using a restriction enzyme, HaeIII in the 
case of proximity MARGI while chromatin was fragmented by sonication in the case of diMARGI. 
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As the fragmentation was using sonication in the case of diMARGI an end repair step was also 
required. This wasn't necessary for pxMARGI. 
 
3. Only the soluble portion of the chromatin was used in the case of diMARGI while the 
insoluble portion was discarded. In the case of pxMARGI both soluble and insoluble chromatin 
was used. 
 
4. A dilute RNAse 1 reaction was used in the case of diMARGI to further fragment RNA. 
This wasn't used in the case of pxMARGI.  
 
 5. Biotinylation reagent: Iodoacetyly-PEG2 Biotin was used in the case of pxMARGI for 
biotinylating proteins. This biotinylates SH groups in Cysteine residues. NHS-Biotin was used in 
the case of diMARGI. This biotinylates any free primary amine group. 
 
6. The streptavidin reagent used was different. Dynabeads streptavidin T1 was used in 
the case of pxMARGI whereas GE Mag sepharose beads were used in the case of diMARGI. 
 
7. Wash conditions for streptavidin - biotinylated protein binding was very stringent in 
the case of diMARGI whereas very mild conditions were used in the case of pxMARGI. 
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8. Nucleic acids were enriched with Silane beads to remove free proteins prior to 
biotinylation in the case of diMARGI. This was not performed in the case of pxMARGI. 
 
2.3 – Experimental controls 
 
We initially used mouse E14 cells to generate MARGI-seq libraries. We generated data 
from three biological replicates for pxMARGI and one for diMARGI. We also performed two 
controls in the case of pxMARGI to show that our protocol detects specific interactions. In one 
case ligation of the linker to RNA was not performed, and in the other control proximity ligation 
was not performed. In the absence of linker ligation to RNA, the linker will be washed away prior 
to proximity ligation. Thus, we should not be able to generate any library. In the absence of 
proximity ligation, the linker is ligated to RNA but exo I and T4 DNA polymerase are used to 
remove the biotin from constructs where linker only ligates to RNA. T4 DNA polymerase has 5' -
> 3' DNA polymerase activity and 3' ->5' exonuclease activity. The polymerase activity is far more 
processive than the exonuclease activity. Thus, the exonuclease can access the biotinylated 
nucleotide only if it is close to the 3' end. This would be true only in the case where the linker did 
not ligate to DNA. Since the biotin is clipped from these molecules, we will not be able to pull 
these molecules down using Streptavidin. Thus, a control where proximity ligation was not 
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performed will also not be also to generate libraries as we would not be able to pull linker 
containing material. 
 
As expected, only the actual sample could generate material that could be sequenced. 
Both the controls failed to generate sufficient material to sequence. As shown in fig. 3 pulled 
down material was used to generate sequencing libraries by performing PCR. In the actual 
sample, enough material to load onto the sequencer was generated by cycle 15. With increasing 
cycle numbers the amount of library produced also increased. In the case of the control even at 
high cycle numbers, very little library was produced. Any material obtained after library 
generation had a band like pattern that most likely was an artifact of just the linker getting 
amplified.  
 
 
 
 
 
 
Fig 3:  Library was generated from E14 cells and sent for sequencing. Two controls were 
also performed. Material was amplified by PCR to generate the library. A. library generated from 
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Fig 3 (...continued) MARGI-seq sample and a proximity ligation control was run on a gel after PCR 
of different cycle numbers. MARGI-seq sample produced an increasing amount of material with 
increasing cycle numbers. Control didn't produce library that could be sequenced even at high 
cycle numbers. B. Library generated from an independent biological replicate of MARGI-seq and 
a control where linker was not ligated to RNA was run on a gel after PCR of different cycles. 
MARGI-seq again produced increasing amounts of library with increasing cycle number. Control 
did not produce at lower cycle numbers. At high cycle numbers, some material was obtained but 
they had a band like pattern, which is most likely an artifact of the linker amplification. C. Gel like 
image of sample sent for sequencing generated using tape station for E14 biological replicate 1. 
 
In order to estimate the extent of non-specific interactions we ran a further control where 
we used a mixture of Drosophila S2 cells and human HEK293T cells to perform pxMARGI. The 
main source of these non-specific interactions would be random ligations in solution. If these 
types of interactions were indeed very high, then a high number of interactions between human 
and drosophila nucleic acids would be detected in our control. 
 
  After cross-linking and cell lysis, the lysates from the two species were mixed before any 
subsequent steps. The mixture was subjected to the rest of the pxMARGI procedure, and 
resulting in a sequenced library. A total of 7,066,395 paired-end reads were mapped to either of 
the two genomes (both ends were uniquely mapped), among which 969,034 (13.71%) had both 
ends mapped to the fly genome (dm6) and 5,942,976 (84.1%) had both ends mapped to the 
25 
 
human genome (hg38), whereas 154,385 (2.18%) had one end mapped to fly genome and the 
other end mapped to human genome. This suggests that random ligations are uncommon in the 
MARGI procedure. 
 
2.4 Sequencing data analysis  
  
 2.4.1 Analysis to assess library quality 
 
As pointed out in the linker design section, one hallmark of our design is that the linker is 
so designed that the read 1 of the paired end data will correspond to information about RNA and 
the read 2 will correspond information about DNA. This implies that when we generate pxMARGI 
data the first two bases of read 2 will correspond to the restriction enzyme signature. The 
restriction enzyme HaeIII recognizes the sequence GGCC and cuts between the G and the C. Thus, 
on sequencing, the first two bases of read 2 in pxMARGI should be CC. The RNA end should be 
randomly distributed. We analyzed the distribution of bases at various positions of the reads was 
analyzed. This is exactly what was observed (Fig 4). 
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Fig 4: Percentage of different bases at different read positions for read 1(RNA) and read 
2 (DNA). Almost 100% of the first two bases of DNA are CC (the restriction enzyme digestion 
signature) whereas the first two bases of the RNA read were randomly distributed. 
 
2.4.2 Mapping of sequences 
 
Our mapping pipeline (depicted in Fig 5) used a splice tolerant aligner (STAR 2.5.1). Unlike 
traditional paired-end alignments where both mates of each pair are simultaneously inputted to 
the aligner tool, we mapped, for each library, the corresponding RNA and DNA reads 
independently. We allowed splice-junctions among RNA reads (where splicing naturally occurs) 
but not among DNA reads. However, as the bases at the 3’ end of either RNA or DNA reads may 
correspond to a chimeric fragment, in both cases we allowed the aligner to clip bases at their 3’ 
end. Also, as per linker design the first two bases on the RNA end are two random nucleotides 
included in the linker. These are clipped from the 5’ end of the RNA. 
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Fig 5: Step by step description of the read mapping procedure. RNA and DNA reads are 
aligned separately before being combined and analyzed together. 
 
Using mm10 as reference genome for mouse, the results (Table 2) show that all replicates 
had a high alignment rate. 
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Table 2: Number of mapped reads and the different types of mapped reads from E14 cells. 
Proximal pairs are RNA-DNA interactions where the DNA target is within 2 kb of the RNA. Distal 
pairs are RNA –DNA interactions where the RNA and DNA are greater than 2 kb apart but on the 
same chromosome. Inter-chromosomal pairs are RNA-DNA interaction where the DNA target of 
RNA-chromatin interactions is on a different chromosome from the source RNA  
 
We also analyzed how the read-pairs mapped to the genome. Paired-end reads from 
chimeric fragments may end up mapped in several possible configurations.  Both the RNA and its 
genomic target could map to the same loci. However, as there is no restriction on how RNA and 
DNA mates are ligated, they can also end up in other nontraditional alignment configurations. 
For instance, both mates may align to different chromosomes, or –when aligned to the same 
chromosome– both mates align to the same strand, or have distances between mates several 
times the size of the length of the fragment selection. While our controls indicate that 
contamination is low, it may also be the case that contamination of non-chimeric fragments (only 
RNA or DNA) show up in the sequencing results. Non-chimeric fragments, however, can only be 
aligned to the reference genome in the same loci. We used this restricted alignment scheme of 
Sample Cell 
line 
Technology Mapped Read Pairs 
Total Proximal Distal Inter-chromosomal 
1 E14 pxMARGI 62,402,150 39,399,542 608,058 2,249,270 
2 E14 pxMARGI 31,201,075 15,453,443 642,280 5,979,803 
3 E14 pxMARGI 23,087,666 21,235,241 74,989 416,502 
4 E14 diMARGI 4,183,169 3,331,533 44,555 787,081 
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non-chimeric fragments to distinguish them from truly chimeric fragments in the case of 
pxMARGI. We categorized the mapped read-pairs as: 
 
Proximal: These are read-pairs where the distance between their outermost coordinates 
of the two reads is lower than 2000 bases. 
 
Distal: These are read-pairs where both mates are mapped to the same chromosome and 
the distance between their outermost coordinates is larger 2000 bases. 
 
Inter-chromosomal: These are reads-pairs where mates are aligned to different 
chromosomes. 
 
 The distribution of these types of reads per library is presented in Table 2. 
 
2.5 Optimization of different steps 
 
We have developed a multi-step strategy based on proximity ligation to identify 
chromatin interacting RNAs and their genomic targets. This is a complex multi-day protocol with 
multiple intermediate steps. In order to obtain the best results, we tested and optimized each 
individual part separately before performing the protocol as a whole. The results of these tests 
are summarized in this section. 
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2.5.1 To optimize the biotinylation of proteins 
 
 In our strategy, we biotinylate proteins in the cell and then localize proteins on 
streptavidin beads before performing the various enzymatic reaction steps. This localization 
helps in making the various buffer changes required. This strategy has also been shown to reduce 
non – specific ligation in the case of Hi-C, a proximity ligation based assay for studying the 3 D 
structure of the genome81.  
 
To biotinylate cells in the pxMARGI protocol, we use a reagent known as Iodoacetyl PEG2 
Biotin. This reagent can biotinylate the free SH group in cysteine residues. The amount of biotin 
used initially was 105 uL of 6.25mM biotin for 25 million cells. We tested the amount of nuclear 
material that could be purified while using 6.25 mM and 62.5 mM biotin solutions. After 
biotinylation, proteins were localized onto Myone Streptavidin C1 beads. Crosslinking was 
reversed and proteins digested away. Nucleic acids were then purified and quantified. This was 
then compared with nucleic acids directly extracted without first biotinylating and pulling down 
proteins. The quantities are summarized below. 
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Table 3: Nucleic acids purified after biotinylation. Nuclear extract from 100 million cells were 
protein biotinylated with two different concentrations of biotin (6.25 mM and 62.5 mM) and 
pulled down with Streptavidin. Nucleic acids were purified and DNA and RNA were quantified. 
 No Biotin Biotin -6.25mM Biotin -62.5 mM 
DNA 128.4 ug 33.6 ug 92.4 ug 
RNA 156 ug 27.8 ug 48.6 ug 
 
 
As seen in table 3, even with 1 X biotin at least 30 % of the nuclear material was localized 
and purified. This means that the biotinylation is very efficient. For the purpose of our 
experiment, we used 105 uL of 62.5 mM biotin (2.5X our lowest concentration tested) per 100 
million cells. 
 
 2.5.2 Restriction enzyme digestion conditions: 
 
The next major step in our pxMARGI protocol is the digestion of DNA with the restriction 
enzyme HaeIII. This enzyme recognizes the sequence GGCC and cuts between the G and C. We 
tested the efficiency of digestion at three conditions. 2000 U for 6 hours, 2000 U for 17 hours and 
4000 U for 6 hours. 2000 U of the enzyme for 6 hours was found to be insufficient for digesting 
the DNA (Fig 6). Both the other conditions digested DNA efficiently. We decided to perform 
digestion for overnight with 2000 U in our protocol. 
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Fig 6: Effect of varying concentration of HaeIII enzyme and of time on the restriction 
enzyme digestion. Chromatin was digested with 4000 U, HaeIII for 6 hours(A) or 2000 U of HaeIII 
for 17 hours (B) or for 2000 U of the enzyme for 6 hours(C). 2000 U for 6 hours wasn't sufficient 
to provide complete digestion. 2000 U of the enzyme for 17 hours or 4000 U of the enzyme for 6 
hours digested DNA very well. 
 
2.5.3 To test the efficiency of ligation of adenylated linkers to RNA  
 
Ligation of the linker to RNA is a critical step of our protocol. Linker ligated RNA is the 
substrate for the downstream proximity ligation step. If this step is not efficient, the amount of 
RNA - DNA interaction that can be identified would reduce significantly. As described earlier, the 
linker we have designed contains a single stranded region on one end and a double stranded 
region on the other end with a dT overhang.  The single stranded end would be preadenylated. 
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Preadenylated DNA can be ligated to RNA using RNA ligase 2 truncated KQ. If DNA is 
preadenylated then the enzyme does not require ATP as a co-factor. This enzyme cannot carry 
out ligation of single stranded RNA. Thus, the number of non-specific RNA ligations would be 
negligible. The efficiency of linker ligation to the RNA would also be theoretically improved. 
 
The efficiency of adenylated linker ligation to our RNA was tested. To do so we purified 
RNA from the cell lysate and then ligated preadenylated linker to this RNA. The linker was 
adenylated using the 5' DNA adenylation kit from NEB. Linker was then purified using silane beads 
and used for the ligation reaction. Ligation products were then pulled down using Streptavidin 
C1 beads and the amount of RNA pulled down was quantified. Amount of RNA in the supernatant 
at the time of pull down was also quantified. These quantifications are summarized in table 4. 
 
Table 4: Quantification of RNA after linker ligation. Purified RNA was ligated in vitro to pre-
adenylated linker. RNA was pulled down using the biotin in the linker and then eluted. RNA was 
then purified from both the supernatant of the pull-down step and the eluate. A control 
experiment with no ligation was also performed 
Sample I/p RNA amount(ng) Eluate RNA amount (ng) Supernatant RNA amount(ng) 
Ligation (+) 1000 400 42 
Ligation (-) 2000 0 1002 
 
The presence of RNA in the supernatant would indicate that RNA did not ligate to the 
linkers and thus could not be pulled down. As seen in table 4, in this case, the amount of RNA in 
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the pulled down fraction was at least one order of magnitude higher than the amount of RNA in 
the supernatant. This would indicate most of the RNA successfully ligate to the linker. The eluate 
contains 40% of the total RNA. Some of the RNA would have been lost during the wash and 
purification steps. Thus we can say that the ligation efficiency was at least 40% and likely higher. 
A gel was run to further verify this (Fig 7). 
 
 
 
 
 
 
 
 
 
Fig 7: Ligated RNA was run on a gel to verify the size distribution of ligation products. The 
linker ligated RNA had a distribution similar to just RNA. Linker alone also produced a smear but 
the smear distribution was much smaller. 
 
2.5.4 To test the efficiency of ligation of linker to DNA 
 
We also tested the efficiency of linker ligation to DNA. To perform this test, an approach 
similar to the one used for testing RNA ligation efficiency, was used. Briefly, DNA was purified 
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from the cell lysate and ligated to biotin containing linker. The linker is designed to have a 3' dT 
overhang. So, DNA was dA-tailed prior to ligation. After ligation DNA was pulled down onto 
Streptavidin C1 beads and then eluted off the beads. The pulled down material was quantified. 
The supernatant after pulldown was also be saved and quantified. This supernatant will be 
compared with the supernatant of a control pulldown of the sample not ligated to biotin linker. 
If the amount of DNA in eluate is much higher or comparable to DNA in the supernatant it would 
mean sufficient amounts of DNA was ligated. Also, DNA in the supernatant of ligated sample 
should be far lesser than DNA in the supernatant from the control sample. 
 
Linker ligated DNA and control DNA were pulled down using Streptavidin C1 beads. 
Supernatant and eluate were both purified using silane beads and quantified using qubit. 
Quantification data is presented in the table below. 
 
Table 5: Quantification after pulldown of DNA ligated to linker. Linker was ligated to DNA and 
pulled down using the biotin in the linker and then eluted. DNA from the supernatant of the pull 
down step as well as the eluate was purified and quantified. A control experiment with no linker 
was also performed 
 
Starting Material Supernatant Eluate 
DNA ligated with linker 5.5 ug DNA + 6.6 ug biotin-linker 1.37 ug  2.1 ug  
DNA without linker 5.5 ug DNA 2.71 ug undetected Qubit 
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As can be seen a significant amount of DNA in the sample that was ligated could be 
observed in the eluate. Also, the amount of DNA in the supernatant of the ligated sample was 
50.5% of the amount of supernatant in the control sample. Assuming that the efficiency of 
purification is the sample for both the samples, the remaining (2.7ug - 1.37ug = 1.34 ug) can be 
considered to have been ligated. This would represent the minimum amount of DNA that was 
ligated as some of the ligated DNA would also be lost during purification. Thus, we can conclude 
that at least 24.5 % of input DNA was ligated (1.34/5.5). If purification losses in the eluate are 
considered to be the same as in the supernatant then we can say that 100 - 50.5 = 49.5 % of DNA 
was ligated. A gel was also run to verify the size distribution of the ligated products, fig 8. As seen 
here, there was no bias in size of pulldown products. 
 
 
 
 
 
 
 
 
Fig 8: Linker was ligated directly to A-tailed DNA. Lane 1: Input DNA. Lane 2: Supernatant 
from sample without linker Lane 3: Eluate from DNA ligated with linker (*) is the excess biotin 
linker which has not been ligated to DNA. Thus, DNA ligated with linker could be successfully 
pulled down while without ligation most of the DNA remained in the supernatant. 
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2.5.5 To test the efficiency and specificity of linker pulldown 
 
The pulldown of the chimeras after proximity ligation is another critical step. If a large 
amount of nucleic acids that are not ligated to the linker gets pulled down, the signal would be 
difficult to differentiate from the noise. To test this, we pulled down samples from three different 
conditions onto Streptavidin C1 beads. One tube contained only linker. The second tube 
contained linker and cell lysate containing DNA and RNA. The third sample was just lysate. After 
pull down, nucleic acids were purified and quantified. Samples were also run on a bioanalyzer 
chip. If this pulldown is very specific the amount of DNA that would be pulled down from the 
samples containing linker should be much higher than the amount of DNA that is pulled down 
from sample containing lysate alone. This is precisely what we observed. 
 
Table 6: Quantification after pulldown of chromatin and linker mixture. Linker was mixed with 
lysate and the mixture was pulled down to purify the linker using its biotin moiety. DNA was then 
quantified.  
Sample Amount Linker I/p (ug) 
Amount lysate (DNA + 
RNA) I/p (ug) 
Amount after 
pulldown (ug) 
Linker only 7.5 0 2.95 
Chromatin + Linker 7.5 20 2.5 
Chromatin only 0 20 0.012 
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 The bioanalyzer data, fig 9. also showed that the DNA pulled down from samples 
containing linker had a very narrow peak at approximately the correct size of the linker. Therefore 
in a sample containing both biotinylated DNA and non-biotinylated DNA, the pulldown enriched 
the biotinylated DNA with high specificity. 
 
 
 
 
 
Fig 9: DNA purified after pulling down biotinylated linker were analyzed on a Bioanalyzer. 
The first panel is pull down of just linker. The second panel is a pulldown of a sample containing 
both linker and nucleic acids from lysate. The third panel is pulldown from a sample containing 
just nucleic acids from lysate. Since the first two panels are extremely similar we can conclude 
that the specificity of pulldown was very high. The pulldown was specifically the linker from a 
mixture of linker and chromatin. 
 
2.5.6 Selection of pH for Phenol: Chloroform extraction: 
 
 While using Phenol: Chloroform for extracting nucleic acids, different pHs are used to 
selectively enrich either RNA or DNA. DNA is supposed to have a higher solubility at pH 4.9 and 
therefore some of it gets separated onto the organic layer when phenol: chloroform of this pH is 
used to purify nucleic acids. Stability of RNA at pH 7.9 is a supposed to be low and therefore long 
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exposure at this pH could lead to degradation of RNA. Since the purification is a relatively fast 
step this may not be a big concern though. As we have both DNA and RNA in our sample we 
decided to test the pH which would be better in our case. Samples were subjected to the protocol 
until the linker ligation subject. After that samples were directly treated with Proteinase K 
solution and then nucleic acids were purified with Phenol: Chloroform of appropriate pH. 
Samples were treated with DNase or RNase, quantified and run on a E-Gel. 
 
 
 
 
 
 
 
 
 
Fig 10: Nucleic acids run on an E-Gel after purifying in Phenol: Chloroform of different pH. 
Nucleic acids were isolated from samples that had either been protein biotinylated and pulled 
down (beads +), or from control nuclear extract (beads -). The gel on the left shows purified 
nucleic acids without any further treatment. The samples on the right were treated with either 
DNase or RNase to show the distribution of RNA or DNA sizes respectively.  Lanes 2-5 on the gel 
to the right were samples treated with DNase and thus showing the distribution of RNA. Lanes 6-
9 were samples treated with RNase and thus showing the size distribution of purified DNA. The 
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Fig 10 (...continued) pH of Phenol: chloroform did not have any significant impact on the 
purification of either RNA or DNA  
 
 There was no significant difference in the amount of nucleic acids purified from either pH. 
Therefore, it was decided that pH 7.9 would be used for the actual experiments as the theoretical 
disadvantage of using pH 4.9 phenol: chloroform was greater than using pH 7.9 phenol: 
chloroform.  
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This chapter contains material previously published in Sridhar, B. et al. Systematic Mapping of RNA-Chromatin Interactions In Vivo. 
Curr. Biol. 27, 602–609 (2017).Figures produced by co-authors have been used as well. 
Chapter 3: RNA – chromatin interactions in human cell lines 
 
 Besides the mouse ES cell line, we applied the MARGI seq protocol in two human cell 
lines. We hypothesized that the interactions between some of the RNAs and chromatin in 
embryonic stem cells and differentiated cells will be different. We, therefore, chose human H9 
ES cells and HEK 293T as the human two cell types we wished to analyze. In this chapter, I will 
provide you with the analysis of the data that we generated in these three cell lines. I will also 
provide a brief discussion of these results and some of the similarities and differences observed 
in the interactions between DNA and RNA in a differentiated cell type versus the embryonic stem 
cells. 
  
 3.1 Data quality metrics 
 
 I have already discussed the initial data quality metrics for the E14 cells in chapter 2. In 
this section, I will discuss the data quality metrics for the human cell types. We performed two 
replicates of pxMARGI for both the cell lines and performed one replicate each for the diMARGI 
protocol. The samples were mapped and classified as before, into three classes – proximal, distal 
and inter-chromosomal. The read numbers for each class have been summarized in the table 
below:  
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Table 7:  Read classification for human cells by interaction type and technology. pxMARGI and 
diMARGI data was obtained from HEK 293T and H9 cells and classified. Proximal pairs are RNA-
DNA interactions where the DNA target is within 2 kb of the RNA. Distal pairs are RNA –DNA 
interactions where the RNA and DNA are greater than 2 kB apart but on the same chromosome. 
Inter-chromosomal pairs are RNA-DNA interactions where the DNA target is on a different 
chromosome from the RNA. 
 
 As can be seen, in the case of pxMARGI, about 15% of interactions were observed to be 
long range (distal and proximal) for both cell types. In the case of diMARGI, this number reduced 
to about 5%. Thus, using both methods we were able to detect a non-trivial amount of long range 
interactions. 
Sample 
ID 
Cell 
type 
Technology 
Mapped read pairs 
Total Proximal Distal 
Inter-
chromosomal 
1 HEK293 pxMARGI 45,187,015 
35,307,650 
(78%) 
722,819 
(2%) 
9,156,546 
(20%) 
2 HEK293 pxMARGI 61,390,133 
51,238,202 
(83%) 
971,270 
(2%) 
9,180,661     
(15 %) 
3 HEK293 diMARGI 9,606,682 
9,006,803 
(94%) 
78,134 (1%) 521,745 (5%) 
4 H9 pxMARGI 29,774,645 
24,015,455 
(81%) 
444,294 
(1%) 
5,314,896 
(18%) 
5 H9 pxMARGI 35,899,884 
29,330,169 
(82%) 
1,414,592 
(4%) 
5,155,123 
(14%) 
6 H9 diMARGI 4,682,327 
4,470,815 
(95%) 
42,479 (1%) 169,033 (4%) 
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We then wished to check if the pxMARGI data still reflected the restriction enzyme 
signature in the pxMARGI protocol for the human cells. We mapped the base composition per 
base for the human cell types.  As expected in pxMARGI almost all the reads had CC in the first 
two bases whereas in diMARGI the distribution was random (Fig 11).  
  
Fig 11: Distribution of the four bases at each position; C(Blue), G(black), T(red) and 
A(green) in libraries generated in 293 T cells using restriction enzyme (A) and sonication (B). In 
the HaeIII library the first two bases consist entirely of CC. 
44 
 
 Once this was observed we proceeded with the analysis of the caRNA. For the purpose of 
this analysis we prioritized the long range interactions. Short range interactions could have 
multiple sources. They could be nascent RNA currently undergoing transcription. There could be 
some artifacts of the sequencing procedure whereby just the DNA or just the RNA was 
sequenced. In order to avoid this, we prioritized the long range interactions.  
  
 3.2 Identity of caRNAs 
 
 The RPKM (Reads per kilobase per million reads) was calculated for the read 1 to identify 
which RNAs could be classified as caRNAs. If the RPKM of a RNA was > 0 it was considered to be 
a caRNA. caRNAs identified by pxMARGI were called as pxRNA while those identified from 
diMARGI protocol were called as diRNA. The total number of non-coding pxRNAs and diRNAs 
(with a FDR < 0.0001 ) identified have been provided in table 8. 
Table 8: Number of non coding pxRNAs and diRNAs  
 
Cell type Number of pxRNAs Number of diRNAs 
HEK 293 T 2864 747 
H9 Human ES 1993 467 
E14 Mouse ES 1541 523 
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Since the nature of interactions being detected by pxMARGI and diMARGI are different 
we expected the RNAs to be detected to also be different. We performed a clustering analysis to 
check if this was indeed the case. As can be seen in Fig 12 the proximity and direct samples 
clustered separately. 
 
 
 
 
 
 
 
 
 
 
Fig 12: Differences in enrichment of RNA and DNA reads among mouse E14 (A) and human 
H9 and HEK cell lines (B) as a result of using proximity and direct MARGI protocols. The letters 
after the cell name represents the protocol used. P for pxMARGI and di for diMARGI. The                 
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Fig 12 (...continued) numbers differentiate the biological replicates. For each library, we 
computed genes’ enrichment of either RNA or DNA reads (RPKM), discarding genes with zero 
values among all libraries. Plotting their first two principal components, it can be clearly observed 
that libraries clustered by protocol.  
  
 We then classified the non-coding pxRNAs and diRNAs by biotype. The largest 
components of non-coding pxRNAs were pseudogene, antisense, and lincRNA, which was the 
same for all the cell types (Figure 13 A). The largest component of diRNAs in both human cell 
types was snoRNA (Figure 13 B), consistent with their known activities for modification of nascent 
target transcripts. The other categories represented in the HEK cells include snRNA and antisense 
RNA. Among the H9 cells the other categories represented include miRNA and snRNA. Among 
the mouse ES cells the largest represented category was the snRNA. The other categories are 
snoRNA and miRNA. All these biotypes have known functions in the nucleus.  
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Fig 13:  Classification of non-coding pxRNAs(A) and diRNAs (B) in HEK, H9 and E14 cells. 
Pseudogenes, antisense and lincRNA were the top categories among the pxRNAs while snoRNA, 
snRNA and miRNA were among the top categories in the diRNAs. 
 
 We then looked for specific examples of RNA with known nuclear locations and 
functions. We concentrated on human cell types for this analysis. The first RNA we looked at 
was XIST. We detected XIST in both H9 and HEK cells among pxRNAs (Fig 14A). XIST expression 
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in ES cells is unstable and naïve ES cells have both X chromosomes active. Human ES cells are 
primed pluripotent cells. X inactivation begins at this stage but XIST transcription is unstable at 
this stage. Thus, the presence of XIST in the pxRNA data is consistent with the reported findings 
about XIST. For the diMARGI data, we noticed that the ES cells had a low signal for XIST but 
among HEK cells, XIST was among the highest ranked RNAs (Fig 14B).  This indicates that in 
differentiated female cells, XIST is indeed among the most important RNAs. But in ES cells these 
interactions haven’t yet fully developed yet.  
     
We then looked at other knows RNAs. We found other RNAs including MALAT1, NEAT1, 
and SNHG1. These were identified as caRNAs in pxMARGI in both cell types. MALAT1, SNHG1, 
and NEAT1 became even more significant in diMARGI, and MALAT1 and SNHG1 rose into the 
few most significant diRNAs in both human cell types. The other RNA we looked at were the 
7SK snRNA in the HEK cells. This was also enriched and I will discuss it further in the genomic 
targets of the caRNA section.   
 
 All the RNAs identified by the pxMARGI and diMARGI techniques can be found on the 
website systembio.ucsd.edu/MARGI/ 
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Fig 14: RNA counts of all the pxRNAs (A) and diRNAs (B) identified in our data plotted by 
gene length. Known caRNAs XIST, MALAT1, NEAT1 and SNHG1 are highlighted. 
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 3.3 Genomic targets of caRNA 
  
 3.3.1 Overview of genomic targets 
  
 We then began analyzing the DNA targets of the caRNAs. We focused on human cells for 
analysis on the DNA ends. 
 
 We called peaks from the DNA ends of the pxMARGI and diMARGI data using MACS 
v1.4.2, which we call pxPeaks and diPeaks respectively. As expected pxPeaks were larger in 
number than diPeaks. Also, pxPeaks were on average larger than the diPeaks. (Fig 15A). HEK cells 
yielded 120,872 pxPeaks, while H9 ES cells yielded 57,154 pxPeaks. In comparison, the amount 
of diPeaks from HEK (7,212) remains larger than that from H9 (5,247), but the difference was not 
as great as that in pxPeaks. This is reminiscent of the idea that pxRNA may be trapped in closed 
chromatin, because stem cell differentiation is usually coupled with chromatin condensation. 
 
 We then assessed if the genomic targets were associated with genomic features. We used 
the Upset tool83 to identify if DNA peaks overlapped with genomic features including promoters, 
5’ UTR, 3’ UTR, exons, introns, downstream sequence (3 kb), and intergenic sequence, while 
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accounting for overlaps to multiple genomic features. In HEK cells, approximately 37% of pxPeaks 
overlapped with intergenic regions and 17% overlapped with promoters (Figure 15B). Adjusting 
for the sizes of these genomic features, pxPeaks were enriched in promoters (Odds ratio = 1.7, 
p-value < 2×10-16, Chi-squared test). H9 cells exhibited very similar proportions, and an 
enrichment in promoters (p-value < 2×10-16).  
 
 The overlaps of diPeaks to promoters increased to 61% (4,391) in HEK and 63% (3,306) in 
ES cells (Figure 15B), and the odds ratios for these overlaps increased to 16.8 (HEK, p-value < 
2×10-16, Chi-squared test) and 17.7 (ES, p-value < 2×10-16, Chi-squared test) (Figure 15B). 
 
 
Fig 15: Size distribution of pxPeaks(Red) and diPeaks(blues) in HEK (solid lines) and 
H9(dashed lines). The size of pxPeaks was on average larger than the size of diPeaks. Proportion 
of pxPeaks and diPeaks overlapping with known genomic features as computed by the Upset     
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Fig 15 (...continued) tool. A large portion of the diPeaks resided in promoters. The enrichment of 
pxPeaks in promoters was also significant. 
 
 3.3.2 Targets of specific caRNAs 
 
 We then analyzed the targets of specific caRNAs. Among the diRNAs originating from the 
X chromosome in HEK 293T cells XIST was the biggest hit. A large portion of the targets of XIST, 
94 % were on the X chromosome as expected with its function in X inactivation. These targets 
were spread across the X chromosome (Fig 16 A). 
 
 The largest targets of MALAT1 and NEAT1 are each other respectively9. Analyzing the DNA 
ends of these NEAT1 RNA was consistent with this (Fig 16B). Similarly, a small nucleolar RNA 
SNHG1 was observed to have several long range interactions (Fig 16 C).  
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Fig 16: The mapped MARGI reads are plotted with Genome Interaction Visualizer (GIVe, 
http://give.genemo.org/?hg38), where the reference genome is plotted horizontally, twice (top 
and bottom bars). The top and the bottom bars can be zoomed in or out independent of each 
other. The mapped RNA ends are shown on the top bar (genome), and the DNA ends are shown 
on the bottom bar (genome). Each MARGI read pair is represented as a line linking the locations 
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Fig 16 (...continued) of RNA end (top) and the DNA end (bottom). The HEK diMARGI data at are 
shown with the XIST locus versus the entire Chromosome X (A),  MALAT1 locus (top) versus the 
entire Chromosome 11 (bottom) (B), and the SNHG1 locus versus the entire Chromosome 11 (C) 
 
We also analyzed the targets of 7SK snRNA. We tried to look at the overlaps of the DNA 
ends of diMARGI with ChIRP-seq data available for 7SK snRNA in 293T cells (Fig 17A). About 12 % 
of the diMARGI data overlapped with ChIRP-seq data (Fig 17B). 91 of 8472 ChIRP seq peaks were 
represented. This represented a p value of less than 1 e -9 
 
 
  
 
 
Fig 17: A Circos representation of targets of 7sK. 7sk is encoded on chromosome 6 but has 
targets throughout the genome. B Venn diagram showing overlap of MARGI reads with ChIRP seq 
peaks. At the intersection the top number, 585 represents number of MARGI reads that                  
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Fig 17 (...continued) overlapped with regions identified as ChIRP-seq peaks. The bottom number, 
91 represents the number of peaks that these reads fell into. 
 
3.4 Correlation of the genomic targets with histone modifications 
 
The genome wide observations led us to directly assess the degree of association between 
promoters and pxRNA. We plotted the density of pxRNA across the 20,000 bp flanking regions of 
every TSS (Figure 18A). Out of 34,475 human genes (GRCh38) with non-redundant TSSs, 23,838 
(69.1%) exhibited increased pxRNA intensities at their TSSs in HEK cells. Even more TSSs (25,392, 
73.7%) exhibited increased pxRNA intensity in H9 cells (Figure 18A).  
 
 Similar to pxRNA, diRNA intensities increased in promoters, but became more 
concentrated; forming sharp peaks centered at TSSs (Figure 18B). A total of 18,135 TSSs in HEK 
and 6,551 TSSs in ES exhibited clear increases of diRNA attachments. 
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Fig18: RNA density in a 20KB region surrounding TSS of every gene in pxMARGI (A) and 
diMARGI (B) respectively. An increase in RNA attachment at the TSS was observed 
 
We asked whether caRNA intensity is correlated with ChIP-seq defined histone 
modification levels. To this end, we calculated RAL (RNA attachment level) for each genomic 
segment as the average read count of the DNA-end of distal and inter-chromosomal read pairs. 
Proximal read pairs were excluded from RAL calculation. Across all TSSs, RAL exhibited positive 
correlations with H3K4me3, H3K27ac, and negative correlation with H3K9me3 (Figure 19 A). 
These correlations were preserved in the datasets generated by pxMARGI and diMARGI.  
 
 We proceeded to analyze the entire genome by scanning the genome with 1,000 bp 
windows. diRNA RAL exhibited positive correlations with H3K4me3 and H3K27ac, and a negative 
correlation with H3K9me3 (Figure 19B). In comparison, pxRNA RAL did not exhibit clear genome-
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wide correlations to H3K4me3 and H3K27ac (Figure 19B), possibly attributable to lack of 
H3K4me3 and H3K27ac in condensed chromatin. Interestingly, pxRNA RAL retained genome-
wide anticorrelation with H3K9me3 (pxMARGI, Figure 19B). Moreover, H3K9me3 was depleted 
in nearly all diPeaks and all pxPeaks (Figure 19C), suggesting a competition between RNA 
attachment and H3K9me3 event in closed chromatin. 
 
 
  
 
 
 
 
 
 
 
Fig 19: (A) H3K4me3, H3K27ac, H3K9me3 (HEK only, no available data in H9), H3K27me3 
(ES only), and expression levels are shown in parallel to the RAL in 20 kb regions flanking the TSS. 
(B) Scatter plots of 1,000 bp genomic windows with histone modification levels (y axis) versus   
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Fig 19 (...continued) RALs (x axis). (C) RAL were plotted for all identified pxPeaks and diPeaks and 
their 20,000 flanking regions. Shown in parallel are H3K9me3 levels in the same regions (green).  
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Chapter 4: Methodology to deploy RNA payloads to specific genomic loci 
 
 The MARGI seq data provides a great overview of the interactions between RNA and 
chromatin. To obtain a deeper insight into these interactions we decided to test another tool – 
CRISPR tethering that can tether RNA to specific genomic loci. 
  
 4.1 CRISPR tethering as a tool to cause and study expression changes 
 
 The CRISPR-Cas9 system has been modified to target RNA to specific genomic loci. Using 
this methodology they were able to tether a few known transcriptional activators/ repressors to 
a reporter and observed small differences (~20%) in expression of the reporter in the expected 
direction79. Luo et. al have used this strategy to target ectopically generated EVX1as lncRNA to 
EVX1/EVX1as promoter80. The effect of this targeting on EVX1 expression was measured. 
Ectopically targeting EVX1as to the EVX1 promoter led to a roughly 2-fold increase in expression 
of EVX1. We wished to develop a system that would be a general-purpose backbone into which 
RNA of interest and coordinates to the target site can be easily cloned. To do so we have 
developed pCRISPTET and tested it with the EVX1as RNA targeted to the EVX1/EVX1as promoter 
locus in E14 cells. 
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 4.1.1 Design and development of pCRISPTET  
  
 We wished to generate a general-purpose backbone vector into which RNA of interest 
can easily be cloned. Since this would be general purpose backbone, expression driven by CMV 
promoter would be better than expression driven by U679  as the CMV promoter was tested with 
longer RNAs as compared to the U6 driven expression. Similarly, the location of RNA of interest 
was chosen to be similar to TOP1 constructs reported by Shechner et.al as again this was tested 
with longer inserts as compared to the INT like constructs. This would mean the RNA of interest 
is present after the guide RNA (Fig 20 A). We designed the pCRISPTET system to contain a 
protospacer cloning site followed by the guide RNA scaffold and a U1 3’ box. The protospacer 
cloning site had recognition sites for the enzyme BbsI so that the protospacer can be easily cloned 
in used a golden gate assembly like reaction (Fig 20B). RNA of interest can be cloned in using 
Gibson assembly at the junction of the gRNA scaffold and the U1 3’ box. (Fig 20 C) 
 
 We first decided to clone EVX1as into pCRISPTET. To do this, we used NEB HiFi assembly 
kit again and introduced the gene between gRNA scaffold and 3’ box regions. We performed 
these steps and obtained a pCRISPTET plasmid that can express EVX1as. We then cloned two 
protospacers that can target these constructs to the EVX1 promoter (sgRNA(a) and sgRNA(b)) as 
well as a control protospacer that targets these constructs to the promoter of an unrelated gene 
(sgRNA(Rex1)).  
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Fig 20: A provides the schematic of the region under expression of CMV promoter in 
pCRISPTET after cloning the protospacer and lncRNA of interest. The CMV promoter drives the 
expression of an RNA that contains the protospacer followed by the gRNA scaffold, followed by 
the lncRNA and a U1 3’ box. B is the sequence of the protospacer cloning site in pCRISPTET. The 
region in blue is the part that is cut by BbSI. The sequences shaded in orange are the BbSI 
recognition sites. C shows the junction between the gRNA scaffold and the u1 3’ box. The 
primers shown in the purple arrows will be used to linearize the plasmid so that the lncRNA of 
interest can be cloned using Gibson assembly/ NEB HiFi assembly. 
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 4.1.2 Effect of CRISPR tethering EVX1as to EVX1 promoter 
 
 These constructs were then transfected into E14 cells and the effect on the expression of 
EVX1 was measured using quantitative PCR. No increase in expression of EVX1 was observed in 
either of the two target loci as compared to the targeting to the control protospacer (Fig 21 A). 
However, since the expression of EVX1 in E14 cells was very low to begin with, we had very high 
technical noise in our qPCR data. To account for this, we repeated the quantification using digital 
PCR. The digital PCR data also did not show any increase in the EVX1 expression (Fig 21 B). If 
anything, a decrease in EVX1 expression was observed with one of the constructs where EVX1as 
was targeted to the EVX1/ EVX1as promoter locus. The input for the digital PCR was cDNA 
generated from equal amounts of total RNA from each sample. Since the readout of the digital 
PCR quantification is an absolute quantification, any discrepancies in quantification or reverse 
transcription efficiencies could also contribute to the differences in quantification. To account 
for these discrepancies, the absolute quantification obtained from the digital PCR experiment 
were normalized by Actin concentration as measured by qPCR and plotted again (Fig 21 C). Even 
after this normalization, no increase in EVX1 expression was observed. Besides the pCRISPTET- 
EVX1as we also constructed a variation where the RNA transcription was driven by the U6 
promoter. In this construct, we attached the lncRNA followed by just the highly conserved region 
of the u1 3’ box to the protospacer and cloned it into pSpgRNA. The final RNA product generated 
was – protospacer-EVX1as lncRNA-U1 3’box-gRNA scaffold. Such a construct has not been 
previously reported and was generated based on the description in Luo et. al. This was an 
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incorrect interpretation of their protocol. Nonetheless, this alternative construct also did not 
cause any increase in the EVX1 expression as measured by qPCR (Fig 21 D) 
  
Fig 21: Analyzed qPCR and dPCR data. A shows the relative expression of EVX1 gene after 
transfection with pCRISPTET expressing EVX1as tagged with three different sgRNAs. The error 
bars are calculated based on the standard deviation of the data. The data for each sample was 
from three wells and represents technical replicates. B represents the quantification of EVX1 
using the dPCR machine. The output of the dPCR machine from three chips per sample was 
plotted here. Error bars represent the standard deviation of this data. C represents the same data 
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Fig 21 (...continued) as in B but normalized by the amounts of Actin as described in the methods 
section. D represents the relative quantification of EVX1 based on a qPCR experiment for samples 
transfected with a modified sgRNA that contained the EVX1as and 19 bases of the U1 3’ box 
sandwiched between the protospacer and the gRNA scaffold. Data represents the mean of three 
wells per sample and the error bars are the standard deviation of this data. 
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This chapter contains material previously published in Sridhar, B. et al. Systematic Mapping of RNA-Chromatin Interactions In Vivo. 
Curr. Biol. 27, 602–609 (2017). Figure produced by co-authors has been used. 
Chapter 5: Discussion 
 
5.1 MARGI-seq as an alternative to current methodologies 
 
 The current techniques to identify RNA-chromatin interactions are ChIRP-seq, CHART-seq, 
and RAP-seq. While these methodologies can identify the interaction sites of a specific RNA, they 
cannot be used for identifying the chromatin associated RNA in the first place. The RNA of interest 
needs to be identified by other methodologies. MARGI-seq circumvents that problem. It is a tool 
that can identify the RNA that interacts with the genome. And thus can be deployed onto studies 
without biasing them beforehand.  
 
 Once the RNA of interest has been identified, the interaction sites of these RNAs can be 
identified using ChIRP-seq, CHART-seq, and RAP-seq. MARGI-seq changes this one-RNA-at-a-time 
paradigm and provides information of all RNAs in one experiment. The number of reads per RNA 
at current depths is definitely not as high as any individual ChIRP-seq, CHART-seq or RAP-seq 
experiment. Future improvements in the MARGI protocol can improve sensitivity. A study 
recently put on the biological preprint repository, bioarxiv, uses a slightly different methodology 
to perform the same experiments84. The results appear (prior to peer review) to have more 
sequences per RNA than MARGI thus showing that further improvements to MARGI-seq’s 
sensitivity is definitely possible.  
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More than five years after ChIRP-seq and CHART-seq were first published only a handful 
of RNAs have been characterized using these methods. Probably, even more RNAs with 
important function in the nucleus have yet not even been identified. MARGI-seq holds the 
potential to identify these RNAs and provide an initial screen to further characterize these RNAs 
with other more sensitive techniques. 
 
5.2 Biological role of RNAs in the nucleus 
 
While the focus of our study was not a deep biological insight into functions of specific 
RNAs we noticed a few interesting cases of biological relevance. 
 
Among the most interesting RNAs we observed was XIST. Both the human cell lines that 
we analyzed were female cells. XIST, as described in the introduction is the lncRNA responsible 
for dosage compensation in mammalian cells. The stage at which XIST inactivation begins has 
been a subject of intense scrutiny and debate. In mouse cells, it has been observed that at early 
stages the paternal X chromosome is inactive by imprinting. At the blastocyst stage, where ESCs 
are derived from, both X chromosomes are active. After implantation, from the epiblast stage 
onwards, random X chromosome inactivation occurs and the cells become XaXi85. Stem cells 
established from cells in the epiblast are called as epiblast stem cells. While mouse embryonic 
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stem cells are considered naïve or ground state, the epiblast stem cells are considered as primed 
pluripotent stage.  
 
While not identical, human embryonic stem cells are seen to be more similar to a primed 
pluripotent stage86. Specifically, with regards to X inactivation, the status is different in different 
cell lines studied87. H9 cells seemed to have X chromosome inactivation marks87 but an effect of 
cell culture condition was also seen88. However, regardless of the presence or absence of XCI 
marks, only a monoallelic expression of genes from the X chromosome was observed in three cell 
lines studied88. 
 
In our data, XIST exhibited pxRNA activity but not diRNA activity in H9 cells (Figure 14). 
Also, in HEK cells which represent a differentiated stage, XIST was one of the top ranked RNAs in 
the diRNA data. This led to a possibility that H9 ES cells represent an intermediate state of X 
chromosome inactivation (XCI).  
 
More specifically, H9 and HEK share XIST involvement in heterochromatin, but XIST also 
attaches to less compact parts of the X chromosome through protein bridges specifically in HEK 
cells. If this was the case, we would anticipate seeing differences in diRNA activities on XIST 
associated lincRNAs TSIX 89,90and FTX 91 between HEK and H9 cells. The two lincRNAs exhibited 
similar degrees of pxRNA activities between HEK and H9 (Figure 22), consistent to the observed 
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XIST pxRNA activities and reported XCI in H9 cells88. However, TSIX and FTX exhibited much 
reduced diRNA activities in H9 as compared to HEK (Figure 22), consistent with the minimal diRNA 
activity of XIST in H9.  
 
 
 
 
 
 
 
 
 
 
Fig 22: pxRNA and diRNA activities of XIST, TSIX, and FTX. RNA-end read counts (y axis) 
plotted against gene length (x axis). 
 Other biologically relevant RNAs that appeared in our dataset were MALAT1 and NEAT1. 
These RNAs are known to localize in different nuclear domains, nuclear speckles and paraspeckles 
respectively. But as seen from previously published data17 they are also one of the strongest 
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targets of each other. This was recapitulated in our dataset in the case of NEAT1. It was previously 
believed that paraspeckles do not interact strongly with the genome. However, our paper further 
strengthens the findings of recent work that NEAT1 does interact with the genome. 
 
5.3 Nuclear body specific RNA and nuclear structure 
 
Nuclear body associated lincRNAs became a theme in the identified diRNA. Among the 
most significant diRNAs (FDR < 0.0001), there were 20 and 22 lincRNAs from HEK and ES cells, 
respectively, of which 12 were shared. Among them, except the 5 without known functions 
(AC084082.3, CH17-373J23.1, CH507-513H4.5, RP11-867G23.3, RP4-561L24.3), the other 7 were 
all associated with nuclear bodies, including nucleolar-specific SNHG8 and SNHG25, Cajal body-
specific SCARNA2, splicing speckle-associated RNU11, RNU12 and RMRP, and nuclear speckle-
specific MALAT1.  
  
One of the most prominent group of RNAs we observed were the small nucleolar RNAs 
(snoRNAs). These snoRNAs localize to the nucleolus and have a role in ribosomal RNA biogenesis 
besides other roles in post transcriptional RNA processing.  
 
The nucleolus is the largest and most prominent sub-nuclear body. It is the site of 
ribosomal transcription and ribosome subunit assembly in the nucleus. Nucleoli are formed 
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around the rDNA repeat sequences and consist of factors required for ribosomal production.  In 
addition to its role in ribosomal assembly, a role for the nucleolus has been uncovered in other 
physiological processes including cell cycle control and stress sensing. The nucleolus has also 
been linked with diseases like cancer, viral infections, and neurodegenerative diseases. 
 
Sub nucleolar structure has been studied extensively using microscopy92. Using electron 
and optical microscopy, we can observe three sub nucleolar compartments, viz. the fibrillar 
centers(FC), the dense fibrillar component(DFC) and the granular component(GC).  The 
composition and locations of these components are linked to their role in rRNA biogenesis. The 
FC contains unengaged RNA pol I. The DFC contains components required for pre-RNA 
processing, with further maturation and assembly happening in the GC. rRNA transcription takes 
place at the border of the FC and DFC. The DFC surrounds the FC and both these components are 
embedded in the GC.  
 
The biomolecular composition of the nucleolus is also relatively well researched. The 
nucleoli are isolated using methods that were established several decades ago93 and the contents 
of the nucleolar material have been subjected to DNA sequencing, RNA sequencing and 
proteomic analysis using mass spectrometry. The DNA associated with the nucleolus has been 
sequenced by two different methodologies – 45494 and Illumina sequencing95. The RNA 
associated with the nucleolus has also been sequenced in 2 different cell types using RNA seq. 
The ENCODE project provides RNA seq data from the nucleolus of K562 cells 1. Cole et. al 
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performed RNA seq analysis on commercially purchased nucleoli of HeLa cells 96. The proteins of 
the nucleolus have been studied using mass spectrometry in multiple studies97,98, mainly to 
understand the dynamics of the nucleolus structure. Andersen et. al.97 annotated 
published/validated nucleolar proteins in their paper. About 32 proteins (out or close to 300) 
proteins identified by them were these validated proteins. This was besides the ribosomal 
proteins. Several studies have uncovered proteins not related to ribosomal RNA processing 
including those involved in stress sensing and cell cycle control. In addition to this, the X 
inactivation center has been shown to be associated with the nucleolus. 
 
However, the interaction and relative localization of these biomolecules is not very well 
characterized. 3C based characterization of the organization of the rDNA genes has been 
published in mouse and rat cells. 99–101. Hi-C data has been analyzed deeply at the rDNA loci in 
two human cell lines, K562, and lymphoblastoid cells99. ChIP-seq data for one of the most 
prominent proteins, nucleolin, is available for HeLa cells 102. In HEK 293T cells ChIP-seq data for 
UBF and RPA116 (the second largest subunit of RNA pol I ) has been published 103.  ChIP-qPCR 
data is available for several more nucleolar protein including RNA pol I, TBF and TTF-I in mouse 
and rat cells 100,101. Beyond that very little protein-DNA interaction data is available. The MARGI-
seq  technique developed by our lab provides whole genome RNA-DNA interaction information 
in HEK293T and H9 cells 104. Among the most prominent RNAs in our diMARGI dataset are the 
snoRNAs and XIST (the DNA end of XIST is in the X inactivation center). XIST is associated with 
nucleolar DNA. Thus, nucleolar RNA-DNA interactions can be inferred using this data.  
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Developing a high resolution map of the nucleolus that brings together information from 
the various available sources (DNA seq, MARGI seq, 3C, HiC) and combining a few new interaction 
datasets (additional ChIP seq) will provide much desired information on the structure of a 
prominent nuclear body.  
 
 5.4 EVX1as in E14 cells 
 
CRISPR tethering of EVX1as to the EVX1/EVX1as promoter locus did not cause any 
increase in the expression of EVX1 in E14 cells. In fact, a consistent decrease in expression was 
observed. This was unexpected. This may be a different mechanism of action of this lncRNA in 
this particular cell line and merits further research which is beyond the scope of this thesis. While 
both the cells are male mouse E.S cells the exact cell line used is different. Also, the initial 
expression of EVX1 gene is very low. Given the low baseline changes in even a small cell 
population at this stage could manifest as overall expression changes. It is possible that Luo et. 
al or we detected such changes. Also in our cloning we observed 3 point mutations in the EVX1as 
sequence. These point mutations could have an effect on the role of EVX1as.  
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Chapter 6: Materials and Methods 
 
6.1 Cell culture 
 
HEK cells were cultured in Dulbecco's modified Eagle medium (DMEM; GIBCO 11960044) 
supplemented with 10% FBS, 2 mM Glutamax (GIBCO 35050061), and 5,000 U/ml 
penicillin/streptomycin (GIBCO 15070063), at 37 ºC with 5 % CO2. 
 
H9 cells were cultured on matrigel (Corning 354277) coated plates and maintained in 
Essential 8 medium (GIBCO A1517001) at 37 ºC with 5 % CO2. 
 
E14 cells were cultured in Dulbecco's modified Eagle medium (DMEM; GIBCO 11960044) 
supplemented with 15% FBS, 2 mM Glutamax (GIBCO 35050061), 1X Non-essential amino acids 
(GIBCO 11140050), 1 mM Sodium pyruvate (GIBCO 11360070) and 5,000 U/ml 
penicillin/streptomycin (GIBCO 15070063), at 37 ºC with 5 % CO2. 
 
Cells were transfected with the appropriate plasmids using lipofectamine 
2000(Invitrogen) using manufacturer’s protocol. 
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6.2 pxMARGI protocol 
 
 6.2.1 Crosslinking 
 
Approximately 400 million cells were crosslinked using 1% Formaldehyde (Thermo Fisher 
28906). Cells grown on 15 cm dishes were rinsed with room temperature PBS. 7 mL 1% 
Formaldehdyde was then added to cells and they were incubated at room temperature for ten 
minutes. Formaldehyde was quenched using an equal volume of 0.25 M glycine. Cells were 
incubated at room temperature for a further 10 minutes. Cells were then washed twice with ice-
cold PBS and scraped from the plate into ice-cold PBS. Cells were pelleted and the pellets flash 
frozen and stored at -80 C. 
 
 6.2.2 Isolation of nuclear material and biotinylation of proteins 
 
 The cell membrane was permeablized using 5 mL NP40 buffer (10 mM Tris, pH 7.5, 10 
mM  NaCl, 0.2 % NP40, 1X Protease inhibitor cocktail). Nuclei were pelleted down and washed 
twice with a mild wash buffer (10 mM Tris, pH 8 (Life Technologies 15568025), 10 mM NaCl, 1mM 
EDTA (Ambion, AM9261). Nuclei were then resuspended in 1250 μL of this wash buffer. Nuclear 
material was isolated by adding 475 μL of 2% SDS (Ambion AM9820) and incubating at 65 C for 
15 minutes. Following this all the proteins are biotinylated so that subsequent reactions can be 
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performed on streptavidin beads. This helps in performing buffer changes and also reduce non-
specific proximity ligation and thus increasing signal to noise ratio81. The biotinylated products 
will be attached to the Strepatavidin at a low surface density on the beads to ensure that ligation 
of non-specific products would be difficult. Protein-biotinylation was carried out by adding 525 
μL of 62.5 mM Iodoacetyl PEG2 biotin (IPB) (Thermo Fisher 21334) to the nuclear extract and 
incubating at room temperature in the dark for 1 hour. IPB attaches to the SH group in cysteine 
residues of proteins. Nuclear material was then diluted in 6.5 mL of 1 X cutsmart buffer (New 
England Biolabs B7204S). The SDS was neutralized by adding 1125 μL of 10% Triton X 100 (Sigma 
T8787-100ML). 
 
 6.2.3 Restriction enzyme digestion of DNA  
 
 Following this, DNA from crosslinked chromatin was digested to a smaller size. A 
restriction enzyme, HaeIII (New England Biolabs R0108M) was chosen to perform this task. HaeIII 
has a 4 base recognition sequence (GGCC) and produces blunt ends. The enzyme digests DNA 
between the G and C in the recognition sequence. In order to perform the restriction digestion, 
300 μL of 10 X cutsmart buffer and 75 μL of HaeIII were added to the solution from the previous 
step, and incubated overnight at 37 C. 
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6.2.4 Removal of excess biotin and pulldown of proteins onto Streptavidin beads: 
  
 In order to remove any unbound biotin, dialysis was performed using a 10 kD MWCO Slide 
– a – lyzer dialysis cassette (Thermo Fisher 87737). Dialysis was performed in 2 L of dialysis buffer 
(10 mM Tris, pH 7.5, 1 mM EDTA). Dialysis was performed for 6 hours at R.T with buffer changes 
every two hours. Buffer was changes one more time and dialysis was continued overnight at 4 C. 
Proteins were pulled down onto 1600 μL Dynabeads MyOne Streptavidin T1 beads (Life 
Technologies 65602). Beads were washed once with PBST (0.01 % Tween 20 (Sigma P9416-50ML) 
and then resuspended in 10 mL of PBST. Bead suspension was then added to digested, and 
dialyzed sample and incubated at room temperature for 1 hour with rotation. Beads were then 
washed once with PBST and thrice with low salt wash buffer (10 mM Tris, pH7.5, 50 mM NaCl, 1 
mM EDTA, 0.4 % Triton X 100).  All reaction on beads except the proximity ligation were carried 
out in the thermomixer with shaking at 800 rpm. 
 
 6.2.5 Preparation of RNA and DNA ends for ligations 
 
 3’ – P present in the RNA was dephosphorylated using T4 PNK with dephosphorylation 
buffer (70 mM Tris, pH 6.5, 10 mM Mg Cl2 , 2 mM DTT). Reaction was performed in 1 mL reaction 
volume with 50 μL of enzyme and 0.1 % Triton X 100. Reaction was carried out at 37 C for 30 
minutes. Pellets were pulled down and beads washed twice with low salt wash buffer.  Exo (-) 
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Klenow (New England Biolabs M0212L) will then be used to add a non templated dA tail. This was 
performed in 1 X NEBuffer 2, with 0.1 mM dATP (New England Biolabs N0440S), 0.1% Triton X 
100 and 36 μL of enzyme.  
 
 6.2.6 Blocking of Streptavidin Beads 
 
 After dA tailing beads were washed twice with low salt wash buffer. Streptavidin was then 
blocked with D-Biotin (Life Technologies B20656). This is done to prevent free biotin tagged linker 
from binding to the Streptavidin and thus prevent ligation of free linker(unligated to RNA) from 
ligating to DNA.  To do this, beads were resuspended in 2 mL of Streptavidin blocking solution 
(100 mM Tris, pH 7, 150 mM NaCl, 10 mM EDTA, 3 mM D- Biotin, 0.01 % Tween 20. Beads were 
incubated with rotation at room temperature for 20 minutes. Beads were pelleted and washed 
thrice with low salt wash buffer and once with PNK wash buffer (20 mM Tris, pH 7.5, 10 mM 
MgCl2, 0.2% Tween 20). 
 
 6.2.7 Ligation of linker to RNA 
 
 Linker ligation would be performed by ligating pre-adenylated linker to the 3’ OH of RNA 
using RNA ligase 2, truncated KQ (New England Biolabs M0373L). This enzyme is a double point 
mutation of RNA ligase 2 truncated and does not need ATP to perform the ligation if the substrate 
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is adenylated at the 5’ end. This provides us with the advantage of preventing any RNA-RNA 
ligations or other undesirable reactions like circularization, as these would need the presence of 
ATP. The Linker sequence has been so designed that it can also be used as the sequencing linker 
for library generation as explained in the main text.  
 
Following oligos were ordered from IDT: 
 
 
 The sense strand was adenylated using the 5’ DNA adenylation kit (New England Biolabs 
E2610L).  900 pmol of the sense strand linker was adenylated by 900 pmol of Mth RNA ligase 
enzyme in a 30 μL reaction of 1 X adenylation buffer in the presence of 0.1 mM ATP. Reaction 
was carried out at 65 C for 1 hour and the enzyme was inactivated by incubating at 85 C for 5 
minutes. Antisense strand was then annealed to the sense strand by adding 900 pmol of the oligo 
and incubating the samples at 95 C for 2 minutes followed by 71 cycles of 20 seconds each 
reducing the temperature by 1 C every cycle. Linkers were then purified using 200 μL Dynabeads 
MyOne Silane beads(Life Technologies 37002D). Following protocol was used for all silane 
purifications unless mentioned otherwise (except the volumes which are mentioned separately 
at each step). Silane beads were washed with Buffer RLT (Qiagen) and then resuspended in 3.5 
sample volumes of buffer RLT. Nucleic acids were added to bead suspension. 4.5 sample volume 
Linker sense 
strand 
5’Phos–
NNAGATCGGAAGAGCGTCGTGTAGGGAGGATCCGTTCAGACGTGTGCTCTTCCGA
/BiodT/CT 
Linker Anti 
Sense Strand 5’ Phos - GATCGGAAGAGCACACGTCTGAACGGATCCTCCCTACACGACGCTCT 
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of isopropanol was added and the tube contents were thoroughly mixed. Sample was incubated 
with beads for 15 minutes at room temperature. Beads were washed twice with 80 % ethanol 
and let to air dry. Sample was eluted in 30 μL of water. Linker was then ligated to the sample 
currently localized on the Streptavidin beads in a 300 μL reaction volume. This reaction was 
carried out in 1 X RNA ligase buffer with 20% PEG 8000, 01% Triton X 100, 900 pmols of linker 
and 15 μL of enzyme. Reaction was carried out at 22 C for 6 hours followed by 16 C overnight. 
 
 6.2.8 Proximity ligation 
 
 The RNA ligation reaction is stopped by adding 30 μL 0.5 M EDTA. Beads were then 
washed five times with low salt wash buffer and thrice with PNK wash buffer. These washes are 
for maximal removal of unligated linker. Beads were then treated with T4 PNK to phosphorylate 
5’ end of DNA in a 1 mL reaction volume. Reaction was carried out in 1 X T4 PNK buffer with 1 
mM ATP(New England Biolabs P0756L), 0.1% Triton X 100 and 50 μL T4 PNK enzyme. Beads were 
pelleted and washed thrice with PNK wash buffer. Proximity ligation was then carried out in a 20 
mL reaction volume. A large volume reduces the probability of non-proximal molecules from 
getting ligated to each other. Reaction was carried out by resuspending beads in 1 X T4 DNA 
ligase buffer with 0.45% Triton X 100, 10 mg BSA (B9000S) and 80000 U of T4 DNA ligase (New 
England Biolabs M0202M). Beads were incubated at 16 C overnight. Ligation was stopped by 
adding 200 μL of 0.5 M EDTA and incubating at 16 C for 15 minutes. 
 
80 
 
 6.2.9 Reverse Crosslinking and DNA/RNA extraction 
 
 Crosslinking was reversed along with a proteinase K digestion by incubating beads in 500 
μL of reverse crosslinking buffer (50 mM Tris, pH 7, 1 % SDS, 1mM EDTA, 100 mM NaCl and 500 
μg of Proteinase K (New England Biolabs P8107S). Reaction was carried out at 55 C for 4 hours. 
Beads were pelleted and nucleic acids extracted from the supernatant using phenol: chloroform, 
pH 7.9 (Ambion AM9730). Nucleic acids were then pelleted by adding 1500 μL ethanol and 50 μL 
3M Sodium Acetate and incubating at -20 C overnight. Nucleic acids were pelleted by centrifuging 
at maximum speed for 30 minutes. Nucleic acids were washed twice with 80 % ethanol and 
resuspended in 100 μL water. 
  
6.2.10 Removal of biotin from non-proximity ligated linkers 
 
 After this biotin was removed from any linkers that ligated only to RNA and not to DNA 
using T4 DNA polymerase. T4 DNA polymerase has two activities. 5’ ->3’ polymerase and 3’-> 5’ 
exonuclease. The polymerase activity is far more processive than the exonuclease activity 
especially at lower temperatures. Under these conditions, only biotinylated nucleotides 
molecules that are close to a 3’ end will be digested.  Nuclei acids are split into 8 aliquots, each 
containing 8 μg of DNA as measured by qubit. They are first treated with exo I (New England 
Biolabs M0293L) to remove any single stranded region at the 3’ end. To do this, to each aliquot 
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of nucleic acid, 15 μL 10 X NEBuffer 2, 1 μL 20 mg/mL BSA, 2 μL RNasin Plus (Promega PRN2615) 
and water to take the volume to 144 μL was added. Samples were incubated at 37 C for 30 
minutes. After this the 3 μL of T4 DNA polymerase (M0203L), 1.5 μL 10 mM dATP and 1.5 μL 10 
mM dGTP (New England Biolabs N0446S) were added. Samples were incubated at 12 C for two 
hours. The 8 aliquots were combined together and the reaction was stopped by adding 20 μL 0.5 
M EDTA.  
 
 6.2.11 Pulldown of chimeras 
 
 At this stage only chimeras will have a biotin tagged linker. Free linkers would have been 
washed after RNA ligation. Any linkers that ligated to RNA but failed to ligate to DNA would have 
the biotin clipped in the previous step. These chimeras would now be pulled down with 
Dynabeads MyOne Strepavidin C 1 beads (Life Technologies 65001). 200 μL Streptavidin C1 beads 
were washed twice with 1 X Binding buffer (5 mM Tris pH 8, 1 M NaCl, 0.5 mM EDTA). Beads were 
resuspended in 1200 μL 2 X Binding buffer (10 mM Tris pH 8, 2 M NaCl, 1 mM EDTA). Samples 
were incubated at RT with rotation for 45 minutes. Washed four times with the following high 
salt buffer (10 mM Tris pH 7, 4 M NaCl, 1 mM EDTA). Beads were then washed twice with low 
salt wash buffer before proceeding to reverse transcription. 
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6.2.12 Reverse transcription of RNA 
 
 The RNA will then be reverse transcribed. Reverse transcriptase can use DNA sequences 
as primers. So the partial double stranded region of the linker will act as the primer for the 
reverse transcription reaction. Reverse transcription was carried out by resuspending the beads 
in a 40 μL reaction volume containing 1 X first strand buffer, 5mM DTT, 0.5 mM dNTPs, 2 μL 
RNasin and 4 μL Supercript III (Life Technologies 18080044). Beads were incubated in a 
thermocycler at 50 C for 1 hour with shaking at 800 rpm. Chimera pulled down and washed twice 
with 1 X binding buffer. Sample was then phosphorylated with T4 PNK in a 100 μL reaction 
volume. Beads were pelleted and washed twice with 1 X binding buffer. 
 
 6.2.13 DNA denaturation 
 
 DNA was then denatured to separate the two strands. The strand with the biotin (and 
also the RNA) will remain attached to the beads while the other strand (containing cDNA) will be 
be eluted into the solution. To do this, beads were resuspended in 100 μL denaturating solution 
(100 mM NaOH( Fisher Scientific AC259860010), 0.1 mM EDTA). Incubated with rotation at RT 
for 15 minutes. Beads were pelleted and supernatant saved. The supernatant was neutralized by 
adding 10 μL 1M HCl (Sigma H1758-100ML ) and 10 μL 1 M Tris, pH 7. The pH of the solution was 
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checked by using pH paper. Single stranded DNA was then purified using 100 μL Silane beads. 
ssDNA is eluted into 15 μL water.  
 
 6.2.14 Circularization 
 
 In order to get the linker which is currently in between RNA and DNA to the ends so that 
it can be used as the linkers for sequencing library generation ssDNA is first circularized and then 
digested at an internal BamH1 site. ssDNA was circularized using circligase (Epicenter CL4111K). 
Reaction was carried out by combining 15 μL ssDNA with 2 μL 10 X Circligase buffer, 1 μL 1mM 
ATP, 1 μL 50 mM MnCl2 and 1 μL Circligase enzyme and incubating at 60 C for four hours. Enzyme 
was inactivated by heating to 80 C for 10 minutes.  
 
 6.2.15 Annealing and digestion 
 
 The linker has a BamH1 site that can be used for digestion. Prior to that an oligo is 
annealed to the linker so that only that region is double stranded and can act as substrate for the 
restriction digestion.  
 
Cut_oligo TCGTGTAGGGAGGATCCGTTCAGACGTGTGCTCT/3InvdT/ 
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To the circularized DNA, 23 μL water, 3μL 10 X cutsmart buffer and 1 μL 10 uM Cut_oligo 
are added. The annealing program of incubating at 95 C for 2 minutes followed by 71 cycles of 
20 seconds each reducing the temperature by 1 C every cycle was then run. 3 μL BamH1 (New 
England Biolabs R3136S) was then added and the reaction is incubated at 37 C for 1 hour. DNA 
was then purified using 100 μL silane beads. DNA was eluted in 25 μL water. 
 
 6.2.16 Sequencing Library Generation 
 
 Sequencing library was generated by amplifying material using NEBnext Hi-fidelity PCR 
enzyme (New England Biolabs M0541S) with NEBnext multiplex oligos for Illumina sequencing 
(New England Biolabs E7335S) as the primers. Multiple test PCRs with 1 μL of sample and 10 μL 
reaction volume were run to identify the correct cycle number for the production run. The 
production PCR was run in a 50 μL reaction volume with 5 μL sample. After the PCR, size selection 
was performed using Ampure XP beads (Beckman Coulter A63880). Library between 200 – 2000 
bp was selected. Library was run on a bioanalyzer to determine the size distribution and then 
paired end sequenced for 100 cycles at each end on an Illumina HiSeq 2500 sequencer.  
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6.3 diMARGI protocol 
 
 6.3.1 Crosslinking 
 
 Cells were crosslinked with two crosslinking agents – formaldehyde (Thermo Fisher 
28906) and disuccinimidyl glutarate (DSG) (Thermo Fisher 20593).  Cells grown on 15 cm dishes 
were first crosslinked with DSG. Cells were washed with PBS once and then rocked with 7 mL per 
15-cm-plate of 2mM DSG for 45 minutes at room temperature. DSG was removed and then cells 
washed once with PBS. Cells were then crosslinked with 7 ml of 3% formaldehyde preheated to 
37oC per 15-cm-plate. Cells were incubated at 37oC for 10 minutes. Formaldehyde was quenched 
by adding Glycine (Fisher BP381-1) to a final concentration of 500 mM and incubating at 37oC for 
5 minutes. Cells were then washed three times with ice-cold PBS and scraped from the plate in 
ice-cold PBS. Cells were pelleted and the pellets flash frozen and stored at -80 C. 
 
 
 6.3.2 Isolation of nuclear material and biotinylation of proteins 
 
 Crosslinked cells were suspended in 10 mL Hypotonic cell lysis buffer (10 mM Tris, pH 7.5 
(Life technologies (15567027), 10 mM  NaCl ( Ambion AM9759),  1X Protease inhibitor cocktail 
(Roche 12352200)) to swell the cells. Cells were pelleted by spinning at 3300× g for 7 minutes. 
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Swelled cells were lysed ice cold cell lysis buffer pre-mixed with 0.1% NP-40 (Sigma I8896-50ML) 
and incubated on ice for 10 minutes. Cells were homogenized by douncing 20 times using the 
pestle A of the dounce homogenizer. Nuclei were pelleted by spinning cells at 3300g for 7 
minutes. The supernatant was discarded. The nuclei were then lysed in 10 mL lysis buffer 
containing buffer RLT (Qiagen 79216) and 2% Sarkosyl (Sigma 61743). The nuclei were split into 
10 of 1 mL aliquots and each aliquot was sonicated in a Covaris ultrasonicator for 5 min. After 
sonication, the lysate was combined and cleared by centrifuging at 16,000g for 10 minutes to 
pellet down the insoluble materials. The supernatant, which contains soluble chromatin (we will 
call this soluble lysate), was collected and used for subsequent steps. This is an important 
difference between the two protocols. Only the soluble lysate is used in the diMARGI protocol 
while both the soluble and insoluble parts are used in the pxMARGI protocol. An equal volume 
of isopropanol and 3 ml of SILANE beads were added to the soluble lysate to isolate complexes 
contain nucleic acids and reduce irrelevant proteins as much as possible. SILANE beads were 
washed 3x with Buffer RWT (Qiagen 1067933) and 3x with 80% ethanol. The beads were air-
dried.  
 
The protein-nucleic acid complexes were protein-biotinylated with NHS-PEG4-Biotin 
(Thermo Fisher 21330). NHS-PEG4-Biotin biotinylates the amine group on the lysine side chain 
and the N-termini. To do so, air-dried SILANE beads were re-suspended in 2 mL 1x PBS. 50 mg of 
NHS-PEG4 biotin was then added to the solution to perform the biotinylation and incubating 
together with the beads overnight at 4oC.   
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6.3.3 Fragmentation of RNA  
  
 RNase I (New England Biolabs M0243S) was diluted 10,000x in PBS. 10 µl of diluted RNase 
I was added per ml of lysate and incubated at 37oC for 3 minutes. 
 
 6.3.4 Removal of excess biotin and pulldown of proteins onto Streptavidin beads 
 
 Excess biotin was removed by rebinding the complexes to SILANE beads by adding 3.5X 
volume of buffer RLT and 4.5X volume of isoproponal and incubating at room temperature for 1 
hour. The beads were washed 3x with 80% ethanol. Complexes were eluted once in 5mL of TE 
buffer (10 mM Tris pH 7.5, 1mM EDTA) plus 0.1% Tween-20 at 37oC for 5 minutes, once in 5mL 
of TE buffer at 37oC for 5 minutes, and once in 5mL of TE buffer plus 6M GuHCl (Thermo Fisher 
24115) at 37oC for 5 minutes.  
 
The biotinylated lysate was next incubated with 2 mL of GE streptavidin beads (GE Life 
Sciences 28-9857-38) in completely denaturing binding buffer (6M GuHCl , 200 mM NaCl, 10mM 
EDTA, 2% N laurlysarcosine, 1mM PMSF (Sigma P7626-5G)) to tether biotinylated protein-
nucleic-acid complexes onto the surface of streptavidin beads. Final volume of binding solution 
including lysate was 40 mL. Binding was carried out overnight at room temperature. Beads were 
washed with 3X with denaturing binding buffer (6M GuHCl , 200 mM NaCl, 10mM EDTA, 2% N 
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laurlysarcosine, 1mM PMSF), 2X with high salt buffer (50 mM Tris pH7.5, 1 M NaCl, 10 mM EDTA, 
0.1% SDS, 1% NP40, 0.5% deoxycholate, 1mM PMSF), 2X with TE wash buffer (10 mM Tris pH 7.5, 
1mM EDTA) and 2X with PNK wash buffer (20 mM Tris pH 7.5, 10 mM MgCl2, 0.2% Triton X-100). 
  
6.3.5 Preparation of RNA and DNA ends for ligations 
 
 Any 3’ – P present in the RNA at this stage was dephosphorylated using T4 Polynucleotide 
kinase (T4 PNK)(New England Biolabs M0201L) using dephosphorylation buffer (70 mM Tris, pH 
6.5, 10 mM Mg Cl2 , 2 mM DTT). Reaction was performed in 1 mL reaction volume with 50 μL of 
enzyme and 0.1 % Triton X 100. Reaction was carried out at 37oC for 30 minutes. Pellets were 
pulled down and beads washed three times with PNK wash buffer (20 mM Tris pH 7.5, 10 mM 
MgCl2, 0.2% Triton X-100).   
 
DNA was blunt-ended by NEBNext End Repair Module (NEB, E6050L) according to the 
manufacturer’s protocol. After the reaction, the beads was washed three times in PNK wash 
buffer (20 mM Tris pH 7.5, 10 mM MgCl2, 0.2% Triton X-100). Exo (-) Klenow (New England 
Biolabs M0212L) was then be used to add a non templated dA tail. This was performed in 1 X 
NEBuffer 2, with 0.1 mM dATP (New England Biolabs N0440S), 0.1% Triton X 100 and 36 μL of 
enzyme.  
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 6.3.6 Blocking of Streptavidin Beads, Ligation of linker to RNA, Proximity ligation, 
Reverse Crosslinking and DNA/RNA extraction, Removal of biotin from non-proximity ligated 
linkers, Pull down of chimeras, Reverse transcription of RNA, DNA denaturation, 
Circularization, oligo annealing and digestion, Sequencing Library Generation 
  
The protocol for these steps is identical to that described in the pxMARGI protocol.  
 
6.4 Protocols for CRISPR tethering 
 
6.4.1 Generating pCRISTET and cloning EVX1as into pCRISPTET 
 
We modified the pcDNA vector, immediately downstream of the CMV promoter, to 
contain the gRNA scaffold, a protospacer cloning site and a lncRNA cloning site and a U1 3’box 
downstream of the lncRNA cloning site using NEB HiFi assembly (New England Biolabs). 
 
We linearized pcDNA using PCR using long range capable PCR enzyme with the following 
primers 
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The following DNA was ordered as a gBlock from IDT.  
 
pCRISPTET
_cassette 
GGGTCTTCGAGAAGACCTGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGT
CCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCACTTTCTGGAGTTTCAAAAGT
AGACTGTACGCTAAGGGTCATATCT 
TTTTTTGTTTGGTTTGTGTCTTGGTTGGCGTCTTAA 
 
The region in bold introduces the cloning site for the protospacer. The underlined region 
is the gRNA scaffold and the rest of the sequences are the U1 3’ box. 
 
The linearized plasmid and the gene block were assembled together using NEB HiFi 
assembly as per the manufacturer’s protocol and transformed into DH5alpha bacteria. Multiple 
clones were picked and sequenced to ensure proper insertion. 
  
To clone EVX1as into pCRISPTET, pCRISPTET was first linearized by PCR using the following 
primers: 
 
pcDNA_linear_fwd tgtcttggttggcgtcttaaAGGCGGAAAGAACCAGCTG 
pcDNA_linear_rev acaggtcttctcgaagacccTTCTCTAGTTAGCCAGAGAGCTCTG 
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pCRISPTET_linear_fwd ACTTTCTGGAGTTTCAAAAG 
pCRISPTET_linear_rev GCACCGACTCGGTGCCAC 
 
EVX1as was amplified from cDNA obtained from Lif (-) E14 cells using the following primers: 
 
EVX1as_pCRISPTET_fwd aagtggcaccgagtcggtgcGAAAGGAGACCCGCAGCTAATG 
EVX1as_pCRISPTET_rev cttttgaaactccagaaagtGGTGGCCCAAGCAAAGGTTTAG 
 
Both the PCR products were recombined using NEB hi Fi assembly and cloned into 
DH5alpha bacteria. Clones were picked and DNA purified. In order to clone the protospacer into 
this plasmid following oligos were ordered from IDT 
 
sgRNA(A) 
 
sgRNA(B)  
sgRNA(Rex1)  
 
These oligos were phosphorylated and then annealed. pCRISPTET containing EVX1as was 
digested with BbSI(New England Biolabs) and ligated to the phosphorylated annealed oligos using 
T7 DNA ligase(New England Biolabs) in a one step reaction using a protocol described by the the 
5’- AGAAGAAAGGAGACCCGCAGCTAA – 3’ 
3’ - CTTTCCTCTGGGCGTCGATTCAAA – 5’ 
3’ - CCCACCTCTTCACTCTGACTCAAA – 5’ 
 5’- AGAAGGGTGGAGAAGTGAGACTGA – 3’ 
3’ - AGGTGCGGCTGGGTTCTGTTCAAA – 5’ 
 5’- AGAATCCACGCCGACCCAAGACAA – 3’ 
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Feng Zhang lab75. This led to the production of pCRISPTET with EVX1as and appropriate 
protospacers. On sequencing 2-3 mismatches were observed in the cloned plasmid over the 700 
bp length of the plasmid. 
 
6.4.2 qPCR and dPCR 
 
48 hours after transfection RNAs were isolated from the cells using Trizol reagent. Equal 
amounts of RNA were reverse transcribed using superscript III with random primers as per 
manufacturer’s protocol. qPCR and dPCR analysis was performed using pre-designed Taqman 
probes from Life Technologies using Quant Studio 3 and Quant studio 3D machines respectively. 
qPCR analysis was performed using the Expression suite software. Beta actin was used as 
endogenous control to normalize data and analyze by delta delta Ct methodology. 
 
6.4.3 Normalization of dPCR data 
 
To account for reverse transcription efficiencies and differences in loading amounts, dPCR 
data was also normalized. Normalization of dPCR data was performed by normalizing each 
sample to amounts of actin. Actin amount would be proportional to 2ି஼೟ಲ೎೟೔೙ . Therefore we 
divided the dPCR data of each sample by 10ହ ∗ 2ି஼೟ಲ೎೟೔೙  to obtain normalized dPCR data. 
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